ID	Gene Name	Species	BBID	BIOCARTA	COG_ONTOLOGY	GOTERM_BP_FAT	GOTERM_CC_FAT	GOTERM_MF_FAT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	PIR_SUPERFAMILY	SMART	UP_SEQ_FEATURE
6358	C-C motif chemokine ligand 14(CCL14)	Homo sapiens							109.Chemokine_families,											GO:1990266~neutrophil migration,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0098771~inorganic ion homeostasis,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0080134~regulation of response to stress,GO:0072676~lymphocyte migration,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0071621~granulocyte chemotaxis,GO:0071356~cellular response to tumor necrosis factor,GO:0071347~cellular response to interleukin-1,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070555~response to interleukin-1,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070371~ERK1 and ERK2 cascade,GO:0070098~chemokine-mediated signaling pathway,GO:0065009~regulation of molecular function,GO:0060326~cell chemotaxis,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0051674~localization of cell,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0050900~leukocyte migration,GO:0050801~ion homeostasis,GO:0050790~regulation of catalytic activity,GO:0050729~positive regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048247~lymphocyte chemotaxis,GO:0045937~positive regulation of phosphate metabolic process,GO:0045087~innate immune response,GO:0044093~positive regulation of molecular function,GO:0043547~positive regulation of GTPase activity,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042127~regulation of cell proliferation,GO:0040011~locomotion,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0034612~response to tumor necrosis factor,GO:0034341~response to interferon-gamma,GO:0034097~response to cytokine,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031325~positive regulation of cellular metabolic process,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030003~cellular cation homeostasis,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0019725~cellular homeostasis,GO:0019221~cytokine-mediated signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009605~response to external stimulus,GO:0008284~positive regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0002548~monocyte chemotaxis,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0000165~MAPK cascade,											GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0048020~CCR chemokine receptor binding,GO:0042379~chemokine receptor binding,GO:0008009~chemokine activity,GO:0005126~cytokine receptor binding,GO:0005125~cytokine activity,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,						IPR001811:Chemokine interleukin-8-like domain,IPR000827:CC chemokine, conserved site,																			hsa04062:Chemokine signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,														SM00199:SCY,				turn,strand,splice variant,signal peptide,sequence variant,sequence conflict,helix,glycosylation site:O-linked (GalNAc...); partial,disulfide bond,chain:HCC-1(9-74),chain:HCC-1(4-74),chain:HCC-1(3-74),chain:CCL15(29-92),chain:CCL15(25-92),chain:CCL15(22-92),chain:C-C motif chemokine 15,chain:C-C motif chemokine 14,									
6348	C-C motif chemokine ligand 3(CCL3)	Homo sapiens							58.(CD40L)_immnosurveillance,35.Chemokines_EAE_Autoreactive_T_Cells,34.Chemokines_in_EAE,33.GProt-coupled_Rec_T_Cell_med_Inflamm,157.14-3-3_Cell_Cycle,109.Chemokine_families,															h_nktPathway:Selective expression of chemokine receptors during T-cell polarization,h_erythPathway:Erythrocyte Differentiation Pathway,								GO:2001141~regulation of RNA biosynthetic process,GO:2000503~positive regulation of natural killer cell chemotaxis,GO:2000501~regulation of natural killer cell chemotaxis,GO:2000403~positive regulation of lymphocyte migration,GO:2000401~regulation of lymphocyte migration,GO:2000147~positive regulation of cell motility,GO:2000145~regulation of cell motility,GO:2000026~regulation of multicellular organismal development,GO:2000021~regulation of ion homeostasis,GO:1990266~neutrophil migration,GO:1904951~positive regulation of establishment of protein localization,GO:1903901~negative regulation of viral life cycle,GO:1903900~regulation of viral life cycle,GO:1903707~negative regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903557~positive regulation of tumor necrosis factor superfamily cytokine production,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1903514~calcium ion transport from endoplasmic reticulum to cytosol,GO:1902679~negative regulation of RNA biosynthetic process,GO:1902656~calcium ion import into cytosol,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1902106~negative regulation of leukocyte differentiation,GO:1902105~regulation of leukocyte differentiation,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901623~regulation of lymphocyte chemotaxis,GO:1901216~positive regulation of neuron death,GO:1901214~regulation of neuron death,GO:0098771~inorganic ion homeostasis,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0097553~calcium ion transmembrane import into cytosol,GO:0097530~granulocyte migration,GO:0097529~myeloid leukocyte migration,GO:0097305~response to alcohol,GO:0090280~positive regulation of calcium ion import,GO:0090279~regulation of calcium ion import,GO:0080134~regulation of response to stress,GO:0072678~T cell migration,GO:0072677~eosinophil migration,GO:0072676~lymphocyte migration,GO:0072511~divalent inorganic cation transport,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0071621~granulocyte chemotaxis,GO:0071407~cellular response to organic cyclic compound,GO:0071396~cellular response to lipid,GO:0071356~cellular response to tumor necrosis factor,GO:0071347~cellular response to interleukin-1,GO:0071346~cellular response to interferon-gamma,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0070997~neuron death,GO:0070887~cellular response to chemical stimulus,GO:0070838~divalent metal ion transport,GO:0070723~response to cholesterol,GO:0070588~calcium ion transmembrane transport,GO:0070555~response to interleukin-1,GO:0070509~calcium ion import,GO:0070374~positive regulation of ERK1 and ERK2 cascade,GO:0070372~regulation of ERK1 and ERK2 cascade,GO:0070371~ERK1 and ERK2 cascade,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0070201~regulation of establishment of protein localization,GO:0070168~negative regulation of biomineral tissue development,GO:0070167~regulation of biomineral tissue development,GO:0070098~chemokine-mediated signaling pathway,GO:0065009~regulation of molecular function,GO:0060402~calcium ion transport into cytosol,GO:0060401~cytosolic calcium ion transport,GO:0060326~cell chemotaxis,GO:0055085~transmembrane transport,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0052472~modulation by host of symbiont transcription,GO:0052312~modulation of transcription in other organism involved in symbiotic interaction,GO:0051931~regulation of sensory perception,GO:0051930~regulation of sensory perception of pain,GO:0051928~positive regulation of calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0051897~positive regulation of protein kinase B signaling,GO:0051896~regulation of protein kinase B signaling,GO:0051851~modification by host of symbiont morphology or physiology,GO:0051817~modification of morphology or physiology of other organism involved in symbiotic interaction,GO:0051707~response to other organism,GO:0051702~interaction with symbiont,GO:0051674~localization of cell,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051402~neuron apoptotic process,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051283~negative regulation of sequestering of calcium ion,GO:0051282~regulation of sequestering of calcium ion,GO:0051272~positive regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051238~sequestering of metal ion,GO:0051235~maintenance of location,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051209~release of sequestered calcium ion into cytosol,GO:0051208~sequestering of calcium ion,GO:0051174~regulation of phosphorus metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051128~regulation of cellular component organization,GO:0051093~negative regulation of developmental process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050921~positive regulation of chemotaxis,GO:0050920~regulation of chemotaxis,GO:0050918~positive chemotaxis,GO:0050900~leukocyte migration,GO:0050877~neurological system process,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050848~regulation of calcium-mediated signaling,GO:0050801~ion homeostasis,GO:0050792~regulation of viral process,GO:0050790~regulation of catalytic activity,GO:0050729~positive regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0050718~positive regulation of interleukin-1 beta secretion,GO:0050716~positive regulation of interleukin-1 secretion,GO:0050715~positive regulation of cytokine secretion,GO:0050714~positive regulation of protein secretion,GO:0050708~regulation of protein secretion,GO:0050707~regulation of cytokine secretion,GO:0050706~regulation of interleukin-1 beta secretion,GO:0050704~regulation of interleukin-1 secretion,GO:0050702~interleukin-1 beta secretion,GO:0050701~interleukin-1 secretion,GO:0050663~cytokine secretion,GO:0048878~chemical homeostasis,GO:0048870~cell motility,GO:0048584~positive regulation of response to stimulus,GO:0048534~hematopoietic or lymphoid organ development,GO:0048525~negative regulation of viral process,GO:0048247~lymphocyte chemotaxis,GO:0048246~macrophage chemotaxis,GO:0048245~eosinophil chemotaxis,GO:0046903~secretion,GO:0046782~regulation of viral transcription,GO:0045937~positive regulation of phosphate metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045671~negative regulation of osteoclast differentiation,GO:0045670~regulation of osteoclast differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0045087~innate immune response,GO:0045055~regulated exocytosis,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044093~positive regulation of molecular function,GO:0044057~regulation of system process,GO:0044033~multi-organism metabolic process,GO:0043922~negative regulation by host of viral transcription,GO:0043921~modulation by host of viral transcription,GO:0043903~regulation of symbiosis, encompassing mutualism through parasitism,GO:0043901~negative regulation of multi-organism process,GO:0043900~regulation of multi-organism process,GO:0043615~astrocyte cell migration,GO:0043547~positive regulation of GTPase activity,GO:0043525~positive regulation of neuron apoptotic process,GO:0043523~regulation of neuron apoptotic process,GO:0043491~protein kinase B signaling,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043308~eosinophil degranulation,GO:0043307~eosinophil activation,GO:0043299~leukocyte degranulation,GO:0043270~positive regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043207~response to external biotic stimulus,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042592~homeostatic process,GO:0042330~taxis,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042063~gliogenesis,GO:0040017~positive regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0036314~response to sterol,GO:0036230~granulocyte activation,GO:0036211~protein modification process,GO:0035821~modification of morphology or physiology of other organism,GO:0035747~natural killer cell chemotaxis,GO:0035556~intracellular signal transduction,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034612~response to tumor necrosis factor,GO:0034341~response to interferon-gamma,GO:0034220~ion transmembrane transport,GO:0034097~response to cytokine,GO:0033993~response to lipid,GO:0033036~macromolecule localization,GO:0032989~cellular component morphogenesis,GO:0032940~secretion by cell,GO:0032897~negative regulation of viral transcription,GO:0032880~regulation of protein localization,GO:0032845~negative regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0032774~RNA biosynthetic process,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032732~positive regulation of interleukin-1 production,GO:0032731~positive regulation of interleukin-1 beta production,GO:0032680~regulation of tumor necrosis factor production,GO:0032652~regulation of interleukin-1 production,GO:0032651~regulation of interleukin-1 beta production,GO:0032640~tumor necrosis factor production,GO:0032612~interleukin-1 production,GO:0032611~interleukin-1 beta production,GO:0032496~response to lipopolysaccharide,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031663~lipopolysaccharide-mediated signaling pathway,GO:0031644~regulation of neurological system process,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031214~biomineral tissue development,GO:0030595~leukocyte chemotaxis,GO:0030593~neutrophil chemotaxis,GO:0030502~negative regulation of bone mineralization,GO:0030500~regulation of bone mineralization,GO:0030335~positive regulation of cell migration,GO:0030334~regulation of cell migration,GO:0030316~osteoclast differentiation,GO:0030282~bone mineralization,GO:0030279~negative regulation of ossification,GO:0030278~regulation of ossification,GO:0030099~myeloid cell differentiation,GO:0030097~hemopoiesis,GO:0030003~cellular cation homeostasis,GO:0030001~metal ion transport,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0019932~second-messenger-mediated signaling,GO:0019725~cellular homeostasis,GO:0019722~calcium-mediated signaling,GO:0019438~aromatic compound biosynthetic process,GO:0019221~cytokine-mediated signaling pathway,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0019083~viral transcription,GO:0019080~viral gene expression,GO:0019058~viral life cycle,GO:0018130~heterocycle biosynthetic process,GO:0016477~cell migration,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016070~RNA metabolic process,GO:0016032~viral process,GO:0015031~protein transport,GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,GO:0014070~response to organic cyclic compound,GO:0012501~programmed cell death,GO:0010959~regulation of metal ion transport,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010818~T cell chemotaxis,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009636~response to toxic substance,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009306~protein secretion,GO:0008360~regulation of cell shape,GO:0008347~glial cell migration,GO:0008219~cell death,GO:0008104~protein localization,GO:0007610~behavior,GO:0007600~sensory perception,GO:0007399~nervous system development,GO:0007267~cell-cell signaling,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007010~cytoskeleton organization,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006935~chemotaxis,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0006887~exocytosis,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0003008~system process,GO:0002762~negative regulation of myeloid leukocyte differentiation,GO:0002761~regulation of myeloid leukocyte differentiation,GO:0002690~positive regulation of leukocyte chemotaxis,GO:0002688~regulation of leukocyte chemotaxis,GO:0002687~positive regulation of leukocyte migration,GO:0002685~regulation of leukocyte migration,GO:0002684~positive regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002573~myeloid leukocyte differentiation,GO:0002548~monocyte chemotaxis,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002447~eosinophil mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002366~leukocyte activation involved in immune response,GO:0002278~eosinophil activation involved in immune response,GO:0002275~myeloid cell activation involved in immune response,GO:0002274~myeloid leukocyte activation,GO:0002263~cell activation involved in immune response,GO:0002252~immune effector process,GO:0002237~response to molecule of bacterial origin,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001775~cell activation,GO:0001649~osteoblast differentiation,GO:0001503~ossification,GO:0000902~cell morphogenesis,GO:0000165~MAPK cascade,											GO:0044421~extracellular region part,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0098772~molecular function regulator,GO:0060229~lipase activator activity,GO:0048020~CCR chemokine receptor binding,GO:0042802~identical protein binding,GO:0042379~chemokine receptor binding,GO:0042056~chemoattractant activity,GO:0031730~CCR5 chemokine receptor binding,GO:0031726~CCR1 chemokine receptor binding,GO:0030234~enzyme regulator activity,GO:0016773~phosphotransferase activity, alcohol group as acceptor,GO:0016301~kinase activity,GO:0016004~phospholipase activator activity,GO:0010857~calcium-dependent protein kinase activity,GO:0009931~calcium-dependent protein serine/threonine kinase activity,GO:0008047~enzyme activator activity,GO:0008009~chemokine activity,GO:0005126~cytokine receptor binding,GO:0005125~cytokine activity,GO:0005102~receptor binding,GO:0004698~calcium-dependent protein kinase C activity,GO:0004697~protein kinase C activity,GO:0004674~protein serine/threonine kinase activity,GO:0004672~protein kinase activity,GO:0001664~G-protein coupled receptor binding,						IPR001811:Chemokine interleukin-8-like domain,IPR000827:CC chemokine, conserved site,																			hsa05323:Rheumatoid arthritis,hsa05142:Chagas disease (American trypanosomiasis),hsa05132:Salmonella infection,hsa04620:Toll-like receptor signaling pathway,hsa04062:Chemokine signaling pathway,hsa04060:Cytokine-cytokine receptor interaction,							609423~HIV infection, resistance to,																			SM00199:SCY,				turn,strand,site:Involved in GAG binding,signal peptide,sequence variant,mutagenesis site,helix,disulfide bond,chain:MIP-1-alpha(4-69),chain:LD78 alpha beta,chain:C-C motif chemokine 3,									
909	CD1a molecule(CD1A)	Homo sapiens						GO:0050776~regulation of immune response,GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib,GO:0048003~antigen processing and presentation of lipid antigen via MHC class Ib,GO:0019884~antigen processing and presentation of exogenous antigen,GO:0019882~antigen processing and presentation,GO:0006955~immune response,GO:0002682~regulation of immune system process,GO:0002475~antigen processing and presentation via MHC class Ib,GO:0002250~adaptive immune response,											GO:0098857~membrane microdomain,GO:0098589~membrane region,GO:0045121~membrane raft,GO:0044440~endosomal part,GO:0044437~vacuolar part,GO:0031226~intrinsic component of plasma membrane,GO:0010008~endosome membrane,GO:0005887~integral component of plasma membrane,GO:0005774~vacuolar membrane,GO:0005773~vacuole,GO:0005768~endosome,															GO:0071723~lipopeptide binding,GO:0042277~peptide binding,GO:0033218~amide binding,GO:0030884~exogenous lipid antigen binding,GO:0030883~endogenous lipid antigen binding,GO:0030882~lipid antigen binding,GO:0030881~beta-2-microglobulin binding,GO:0008289~lipid binding,GO:0003823~antigen binding,						IPR013783:Immunoglobulin-like fold,IPR011162:MHC classes I/II-like antigen recognition protein,IPR011161:MHC class I-like antigen recognition,IPR007110:Immunoglobulin-like domain,IPR003597:Immunoglobulin C1-set,																			hsa04640:Hematopoietic cell lineage,														SM00407:IGc1,				turn,transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,signal peptide,sequence variant,sequence conflict,region of interest:Glycolipid binding,helix,glycosylation site:N-linked (GlcNAc...),domain:Ig-like,disulfide bond,chain:T-cell surface glycoprotein CD1a,binding site:Glycolipid,									
914	CD2 molecule(CD2)	Homo sapiens							99.NF-kB_activation,90.IB_and-cat-Arm_processing_of_Ci,81.Structure_of_Caps_and_SMACs,7.IL17_hematopoesis,150.caspase_and_NFKB_activation,															h_thelperPathway:T Helper Cell Surface Molecules,h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules,h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents,h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells,h_il17Pathway:IL 17 Signaling Pathway,h_dcPathway:Dendritic cells in regulating TH1 and TH2 Development,								GO:2000484~positive regulation of interleukin-8 secretion,GO:2000482~regulation of interleukin-8 secretion,GO:2000026~regulation of multicellular organismal development,GO:1904951~positive regulation of establishment of protein localization,GO:1903706~regulation of hemopoiesis,GO:1903557~positive regulation of tumor necrosis factor superfamily cytokine production,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1903037~regulation of leukocyte cell-cell adhesion,GO:1902715~positive regulation of interferon-gamma secretion,GO:1902713~regulation of interferon-gamma secretion,GO:1902580~single-organism cellular localization,GO:1902105~regulation of leukocyte differentiation,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0072643~interferon-gamma secretion,GO:0072606~interleukin-8 secretion,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0071593~lymphocyte aggregation,GO:0070489~T cell aggregation,GO:0070486~leukocyte aggregation,GO:0070201~regulation of establishment of protein localization,GO:0061024~membrane organization,GO:0051674~localization of cell,GO:0051668~localization within membrane,GO:0051665~membrane raft localization,GO:0051641~cellular localization,GO:0051249~regulation of lymphocyte activation,GO:0051240~positive regulation of multicellular organismal process,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050900~leukocyte migration,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050863~regulation of T cell activation,GO:0050715~positive regulation of cytokine secretion,GO:0050714~positive regulation of protein secretion,GO:0050708~regulation of protein secretion,GO:0050707~regulation of cytokine secretion,GO:0050663~cytokine secretion,GO:0048870~cell motility,GO:0048534~hematopoietic or lymphoid organ development,GO:0046903~secretion,GO:0046649~lymphocyte activation,GO:0045619~regulation of lymphocyte differentiation,GO:0045595~regulation of cell differentiation,GO:0045580~regulation of T cell differentiation,GO:0045321~leukocyte activation,GO:0045184~establishment of protein localization,GO:0044802~single-organism membrane organization,GO:0042110~T cell activation,GO:0040011~locomotion,GO:0034113~heterotypic cell-cell adhesion,GO:0033036~macromolecule localization,GO:0032940~secretion by cell,GO:0032880~regulation of protein localization,GO:0032760~positive regulation of tumor necrosis factor production,GO:0032757~positive regulation of interleukin-8 production,GO:0032729~positive regulation of interferon-gamma production,GO:0032680~regulation of tumor necrosis factor production,GO:0032677~regulation of interleukin-8 production,GO:0032649~regulation of interferon-gamma production,GO:0032640~tumor necrosis factor production,GO:0032637~interleukin-8 production,GO:0032609~interferon-gamma production,GO:0031580~membrane raft distribution,GO:0031579~membrane raft organization,GO:0030887~positive regulation of myeloid dendritic cell activation,GO:0030885~regulation of myeloid dendritic cell activation,GO:0030155~regulation of cell adhesion,GO:0030101~natural killer cell activation,GO:0030098~lymphocyte differentiation,GO:0030097~hemopoiesis,GO:0022610~biological adhesion,GO:0022407~regulation of cell-cell adhesion,GO:0016477~cell migration,GO:0016337~single organismal cell-cell adhesion,GO:0015031~protein transport,GO:0012501~programmed cell death,GO:0009306~protein secretion,GO:0008219~cell death,GO:0008104~protein localization,GO:0007166~cell surface receptor signaling pathway,GO:0007159~leukocyte cell-cell adhesion,GO:0007155~cell adhesion,GO:0006928~movement of cell or subcellular component,GO:0006915~apoptotic process,GO:0002696~positive regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002521~leukocyte differentiation,GO:0002520~immune system development,GO:0002274~myeloid leukocyte activation,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001775~cell activation,GO:0001773~myeloid dendritic cell activation,GO:0001766~membrane raft polarization,											GO:0098562~cytoplasmic side of membrane,GO:0098552~side of membrane,GO:0046658~anchored component of plasma membrane,GO:0031226~intrinsic component of plasma membrane,GO:0031225~anchored component of membrane,GO:0030054~cell junction,GO:0009986~cell surface,GO:0009898~cytoplasmic side of plasma membrane,GO:0009897~external side of plasma membrane,GO:0005911~cell-cell junction,GO:0005887~integral component of plasma membrane,GO:0005576~extracellular region,															GO:0060089~molecular transducer activity,GO:0046983~protein dimerization activity,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0005102~receptor binding,GO:0004872~receptor activity,						IPR015632:T-cell adhesion molecule CD2,IPR013783:Immunoglobulin-like fold,IPR013106:Immunoglobulin V-set,IPR008424:Immunoglobulin C2-set,IPR007110:Immunoglobulin-like domain,																			hsa04640:Hematopoietic cell lineage,hsa04514:Cell adhesion molecules (CAMs),						turn,transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,signal peptide,sequence variant,sequence conflict,region of interest:LFA-3 (CD58) binding region 2,region of interest:LFA-3 (CD58) binding region 1,mutagenesis site,helix,glycosylation site:N-linked (GlcNAc...),domain:Ig-like V-type,domain:Ig-like C2-type,disulfide bond,compositionally biased region:Pro-rich,chain:T-cell surface antigen CD2,									
963	CD53 molecule(CD53)	Homo sapiens						GO:1901741~positive regulation of myoblast fusion,GO:1901739~regulation of myoblast fusion,GO:0061061~muscle structure development,GO:0060143~positive regulation of syncytium formation by plasma membrane fusion,GO:0060142~regulation of syncytium formation by plasma membrane fusion,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0042692~muscle cell differentiation,GO:0022603~regulation of anatomical structure morphogenesis,GO:0014902~myotube differentiation,GO:0010831~positive regulation of myotube differentiation,GO:0010830~regulation of myotube differentiation,GO:0007520~myoblast fusion,GO:0007166~cell surface receptor signaling pathway,GO:0006949~syncytium formation,GO:0000768~syncytium formation by plasma membrane fusion,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0031226~intrinsic component of plasma membrane,GO:0030054~cell junction,GO:0009986~cell surface,GO:0005911~cell-cell junction,GO:0005887~integral component of plasma membrane,GO:0005576~extracellular region,GO:0001772~immunological synapse,									IPR018503:Tetraspanin, conserved site,IPR018499:Tetraspanin/Peripherin,IPR008952:Tetraspanin, EC2 domain,IPR000301:Tetraspanin,											PIRSF002419:tetraspanin,														transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,glycosylation site:N-linked (GlcNAc...),chain:Leukocyte surface antigen CD53,									
2205	Fc fragment of IgE receptor Ia(FCER1A)	Homo sapiens										h_fcer1Pathway:Fc Epsilon Receptor I Signaling in Mast Cells,								GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1903307~positive regulation of regulated secretory pathway,GO:1903305~regulation of regulated secretory pathway,GO:1902582~single-organism intracellular transport,GO:1902580~single-organism cellular localization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:0080135~regulation of cellular response to stress,GO:0080134~regulation of response to stress,GO:0072330~monocarboxylic acid biosynthetic process,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071705~nitrogen compound transport,GO:0070304~positive regulation of stress-activated protein kinase signaling cascade,GO:0070302~regulation of stress-activated protein kinase signaling cascade,GO:0065009~regulation of molecular function,GO:0060627~regulation of vesicle-mediated transport,GO:0060341~regulation of cellular localization,GO:0051656~establishment of organelle localization,GO:0051649~establishment of localization in cell,GO:0051641~cellular localization,GO:0051640~organelle localization,GO:0051403~stress-activated MAPK cascade,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050850~positive regulation of calcium-mediated signaling,GO:0050848~regulation of calcium-mediated signaling,GO:0050790~regulation of catalytic activity,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050729~positive regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0048584~positive regulation of response to stimulus,GO:0046907~intracellular transport,GO:0046903~secretion,GO:0046456~icosanoid biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0046330~positive regulation of JNK cascade,GO:0046328~regulation of JNK cascade,GO:0045937~positive regulation of phosphate metabolic process,GO:0045921~positive regulation of exocytosis,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045576~mast cell activation,GO:0045425~positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,GO:0045423~regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,GO:0045401~positive regulation of interleukin-3 biosynthetic process,GO:0045399~regulation of interleukin-3 biosynthetic process,GO:0045321~leukocyte activation,GO:0045055~regulated exocytosis,GO:0044283~small molecule biosynthetic process,GO:0044255~cellular lipid metabolic process,GO:0044093~positive regulation of molecular function,GO:0043549~regulation of kinase activity,GO:0043507~positive regulation of JUN kinase activity,GO:0043506~regulation of JUN kinase activity,GO:0043436~oxoacid metabolic process,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043406~positive regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043306~positive regulation of mast cell degranulation,GO:0043304~regulation of mast cell degranulation,GO:0043303~mast cell degranulation,GO:0043302~positive regulation of leukocyte degranulation,GO:0043300~regulation of leukocyte degranulation,GO:0043299~leukocyte degranulation,GO:0043085~positive regulation of catalytic activity,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042253~granulocyte macrophage colony-stimulating factor biosynthetic process,GO:0042223~interleukin-3 biosynthetic process,GO:0042108~positive regulation of cytokine biosynthetic process,GO:0042107~cytokine metabolic process,GO:0042089~cytokine biosynthetic process,GO:0042035~regulation of cytokine biosynthetic process,GO:0038095~Fc-epsilon receptor signaling pathway,GO:0038093~Fc receptor signaling pathway,GO:0036211~protein modification process,GO:0035556~intracellular signal transduction,GO:0033674~positive regulation of kinase activity,GO:0033559~unsaturated fatty acid metabolic process,GO:0033554~cellular response to stress,GO:0033008~positive regulation of mast cell activation involved in immune response,GO:0033006~regulation of mast cell activation involved in immune response,GO:0033005~positive regulation of mast cell activation,GO:0033003~regulation of mast cell activation,GO:0032940~secretion by cell,GO:0032874~positive regulation of stress-activated MAPK cascade,GO:0032872~regulation of stress-activated MAPK cascade,GO:0032787~monocarboxylic acid metabolic process,GO:0032752~positive regulation of interleukin-3 production,GO:0032725~positive regulation of granulocyte macrophage colony-stimulating factor production,GO:0032672~regulation of interleukin-3 production,GO:0032645~regulation of granulocyte macrophage colony-stimulating factor production,GO:0032632~interleukin-3 production,GO:0032604~granulocyte macrophage colony-stimulating factor production,GO:0032418~lysosome localization,GO:0032388~positive regulation of intracellular transport,GO:0032386~regulation of intracellular transport,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032147~activation of protein kinase activity,GO:0032103~positive regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031349~positive regulation of defense response,GO:0031347~regulation of defense response,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031098~stress-activated protein kinase signaling cascade,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0019932~second-messenger-mediated signaling,GO:0019752~carboxylic acid metabolic process,GO:0019724~B cell mediated immunity,GO:0019722~calcium-mediated signaling,GO:0019370~leukotriene biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0018212~peptidyl-tyrosine modification,GO:0018193~peptidyl-amino acid modification,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0017157~regulation of exocytosis,GO:0016310~phosphorylation,GO:0016192~vesicle-mediated transport,GO:0016068~type I hypersensitivity,GO:0016064~immunoglobulin mediated immune response,GO:0016053~organic acid biosynthetic process,GO:0015850~organic hydroxy compound transport,GO:0015844~monoamine transport,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009605~response to external stimulus,GO:0008610~lipid biosynthetic process,GO:0007257~activation of JUN kinase activity,GO:0007254~JNK cascade,GO:0007166~cell surface receptor signaling pathway,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006887~exocytosis,GO:0006837~serotonin transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006691~leukotriene metabolic process,GO:0006690~icosanoid metabolic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0006633~fatty acid biosynthetic process,GO:0006631~fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006082~organic acid metabolic process,GO:0002891~positive regulation of immunoglobulin mediated immune response,GO:0002889~regulation of immunoglobulin mediated immune response,GO:0002888~positive regulation of myeloid leukocyte mediated immunity,GO:0002886~regulation of myeloid leukocyte mediated immunity,GO:0002885~positive regulation of hypersensitivity,GO:0002883~regulation of hypersensitivity,GO:0002866~positive regulation of acute inflammatory response to antigenic stimulus,GO:0002864~regulation of acute inflammatory response to antigenic stimulus,GO:0002863~positive regulation of inflammatory response to antigenic stimulus,GO:0002861~regulation of inflammatory response to antigenic stimulus,GO:0002824~positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002822~regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002821~positive regulation of adaptive immune response,GO:0002819~regulation of adaptive immune response,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002714~positive regulation of B cell mediated immunity,GO:0002712~regulation of B cell mediated immunity,GO:0002708~positive regulation of lymphocyte mediated immunity,GO:0002706~regulation of lymphocyte mediated immunity,GO:0002705~positive regulation of leukocyte mediated immunity,GO:0002703~regulation of leukocyte mediated immunity,GO:0002699~positive regulation of immune effector process,GO:0002697~regulation of immune effector process,GO:0002696~positive regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002675~positive regulation of acute inflammatory response,GO:0002673~regulation of acute inflammatory response,GO:0002526~acute inflammatory response,GO:0002524~hypersensitivity,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002449~lymphocyte mediated immunity,GO:0002448~mast cell mediated immunity,GO:0002444~myeloid leukocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002438~acute inflammatory response to antigenic stimulus,GO:0002437~inflammatory response to antigenic stimulus,GO:0002366~leukocyte activation involved in immune response,GO:0002279~mast cell activation involved in immune response,GO:0002275~myeloid cell activation involved in immune response,GO:0002274~myeloid leukocyte activation,GO:0002263~cell activation involved in immune response,GO:0002252~immune effector process,GO:0002250~adaptive immune response,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001820~serotonin secretion,GO:0001819~positive regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001812~positive regulation of type I hypersensitivity,GO:0001810~regulation of type I hypersensitivity,GO:0001775~cell activation,GO:0000187~activation of MAPK activity,GO:0000165~MAPK cascade,											GO:0098552~side of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005887~integral component of plasma membrane,															GO:0099600~transmembrane receptor activity,GO:0060089~molecular transducer activity,GO:0044877~macromolecular complex binding,GO:0038023~signaling receptor activity,GO:0032403~protein complex binding,GO:0019865~immunoglobulin binding,GO:0019863~IgE binding,GO:0019767~IgE receptor activity,GO:0019763~immunoglobulin receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,						IPR013783:Immunoglobulin-like fold,IPR013151:Immunoglobulin,IPR007110:Immunoglobulin-like domain,IPR003599:Immunoglobulin subtype,IPR003598:Immunoglobulin subtype 2,																			hsa05310:Asthma,hsa04664:Fc epsilon RI signaling pathway,hsa04071:Sphingolipid signaling pathway,														SM00409:IG,SM00408:IGc2,				transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,signal peptide,sequence variant,helix,glycosylation site:N-linked (GlcNAc...),domain:Ig-like 2,domain:Ig-like 1,disulfide bond,chain:High affinity immunoglobulin epsilon receptor subunit alpha,									
2214	Fc fragment of IgG receptor IIIa(FCGR3A)	Homo sapiens							56.Macrophage_regulation_of_CD4+T_cells,											GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0048584~positive regulation of response to stimulus,GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038094~Fc-gamma receptor signaling pathway,GO:0038093~Fc receptor signaling pathway,GO:0016192~vesicle-mediated transport,GO:0007166~cell surface receptor signaling pathway,GO:0006955~immune response,GO:0006909~phagocytosis,GO:0006897~endocytosis,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002433~immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,GO:0002431~Fc receptor mediated stimulatory signaling pathway,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002253~activation of immune response,GO:0002252~immune effector process,											GO:1903561~extracellular vesicle,GO:0098552~side of membrane,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005576~extracellular region,															GO:0044877~macromolecular complex binding,GO:0032403~protein complex binding,GO:0019865~immunoglobulin binding,GO:0019864~IgG binding,						IPR013783:Immunoglobulin-like fold,IPR007110:Immunoglobulin-like domain,IPR003599:Immunoglobulin subtype,																			hsa05322:Systemic lupus erythematosus,hsa05152:Tuberculosis,hsa05150:Staphylococcus aureus infection,hsa05140:Leishmaniasis,hsa04650:Natural killer cell mediated cytotoxicity,hsa04380:Osteoclast differentiation,hsa04145:Phagosome,							615707~Immunodeficiency 20,																			SM00409:IG,				transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,signal peptide,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),domain:Ig-like C2-type 2,domain:Ig-like C2-type 1,disulfide bond,chain:Low affinity immunoglobulin gamma Fc region receptor III-A,									
158835	acyl-CoA wax alcohol acyltransferase 2(AWAT2)	Homo sapiens						GO:1901615~organic hydroxy compound metabolic process,GO:0046486~glycerolipid metabolic process,GO:0044255~cellular lipid metabolic process,GO:0042572~retinol metabolic process,GO:0042445~hormone metabolic process,GO:0036155~acylglycerol acyl-chain remodeling,GO:0034754~cellular hormone metabolic process,GO:0034308~primary alcohol metabolic process,GO:0016101~diterpenoid metabolic process,GO:0010817~regulation of hormone levels,GO:0010166~wax metabolic process,GO:0010025~wax biosynthetic process,GO:0006721~terpenoid metabolic process,GO:0006720~isoprenoid metabolic process,GO:0006639~acylglycerol metabolic process,GO:0006638~neutral lipid metabolic process,GO:0006629~lipid metabolic process,GO:0006066~alcohol metabolic process,GO:0001523~retinoid metabolic process,											GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,															GO:0103095~wax ester synthase activity,GO:0050252~retinol O-fatty-acyltransferase activity,GO:0047196~long-chain-alcohol O-fatty-acyltransferase activity,GO:0016747~transferase activity, transferring acyl groups other than amino-acyl groups,GO:0016746~transferase activity, transferring acyl groups,GO:0016411~acylglycerol O-acyltransferase activity,GO:0008374~O-acyltransferase activity,GO:0003846~2-acylglycerol O-acyltransferase activity,						IPR007130:Diacylglycerol acyltransferase,																			hsa04977:Vitamin digestion and absorption,hsa00830:Retinol metabolism,						transmembrane region,chain:Acyl-CoA wax alcohol acyltransferase 2,									
712	complement C1q A chain(C1QA)	Homo sapiens										h_compPathway:Complement Pathway,h_classicPathway:Classical Complement Pathway,								GO:1990267~response to transition metal nanoparticle,GO:0072376~protein activation cascade,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0048584~positive regulation of response to stimulus,GO:0045087~innate immune response,GO:0019724~B cell mediated immunity,GO:0016064~immunoglobulin mediated immune response,GO:0010039~response to iron ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0007267~cell-cell signaling,GO:0006959~humoral immune response,GO:0006958~complement activation, classical pathway,GO:0006956~complement activation,GO:0006955~immune response,GO:0006952~defense response,GO:0006508~proteolysis,GO:0002684~positive regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002460~adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002455~humoral immune response mediated by circulating immunoglobulin,GO:0002449~lymphocyte mediated immunity,GO:0002443~leukocyte mediated immunity,GO:0002253~activation of immune response,GO:0002252~immune effector process,GO:0002250~adaptive immune response,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0005615~extracellular space,GO:0005602~complement component C1 complex,GO:0005581~collagen trimer,GO:0005576~extracellular region,															GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0017171~serine hydrolase activity,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,						IPR008983:Tumour necrosis factor-like domain,IPR008160:Collagen triple helix repeat,IPR001073:Complement C1q protein,																			hsa05322:Systemic lupus erythematosus,hsa05150:Staphylococcus aureus infection,hsa05142:Chagas disease (American trypanosomiasis),hsa05133:Pertussis,hsa05020:Prion diseases,hsa04610:Complement and coagulation cascades,							613652~C1q deficiency,																			SM00110:C1Q,				turn,strand,signal peptide,sequence variant,sequence conflict,modified residue,glycosylation site:O-linked (Gal...),glycosylation site:N-linked (GlcNAc...),domain:Collagen-like,domain:C1q,disulfide bond,chain:Complement C1q subcomponent subunit A,									
1469	cystatin SN(CST1)	Homo sapiens						GO:2000117~negative regulation of cysteine-type endopeptidase activity,GO:2000116~regulation of cysteine-type endopeptidase activity,GO:0065009~regulation of molecular function,GO:0052548~regulation of endopeptidase activity,GO:0052547~regulation of peptidase activity,GO:0051606~detection of stimulus,GO:0051346~negative regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051248~negative regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0050913~sensory perception of bitter taste,GO:0050912~detection of chemical stimulus involved in sensory perception of taste,GO:0050909~sensory perception of taste,GO:0050907~detection of chemical stimulus involved in sensory perception,GO:0050906~detection of stimulus involved in sensory perception,GO:0050877~neurological system process,GO:0050790~regulation of catalytic activity,GO:0045861~negative regulation of proteolysis,GO:0044092~negative regulation of molecular function,GO:0043086~negative regulation of catalytic activity,GO:0032269~negative regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030162~regulation of proteolysis,GO:0010951~negative regulation of endopeptidase activity,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010466~negative regulation of peptidase activity,GO:0009892~negative regulation of metabolic process,GO:0009593~detection of chemical stimulus,GO:0007606~sensory perception of chemical stimulus,GO:0007600~sensory perception,GO:0006508~proteolysis,GO:0003008~system process,GO:0001580~detection of chemical stimulus involved in sensory perception of bitter taste,											GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0098772~molecular function regulator,GO:0061135~endopeptidase regulator activity,GO:0061134~peptidase regulator activity,GO:0030414~peptidase inhibitor activity,GO:0030234~enzyme regulator activity,GO:0019899~enzyme binding,GO:0004869~cysteine-type endopeptidase inhibitor activity,GO:0004866~endopeptidase inhibitor activity,GO:0004857~enzyme inhibitor activity,GO:0002020~protease binding,						IPR027214:Cystatin,IPR018073:Proteinase inhibitor I25, cystatin, conserved site,IPR000010:Proteinase inhibitor I25, cystatin,																			hsa04970:Salivary secretion,														SM00043:CY,				site:Reactive site,signal peptide,short sequence motif:Secondary area of contact,sequence variant,disulfide bond,chain:Cystatin-SN,									
1576	cytochrome P450 family 3 subfamily A member 4(CYP3A4)	Homo sapiens										h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,														Secondary metabolites biosynthesis, transport, and catabolism,						GO:1902652~secondary alcohol metabolic process,GO:1901617~organic hydroxy compound biosynthetic process,GO:1901615~organic hydroxy compound metabolic process,GO:1901565~organonitrogen compound catabolic process,GO:1901361~organic cyclic compound catabolic process,GO:0071466~cellular response to xenobiotic stimulus,GO:0070989~oxidative demethylation,GO:0070988~demethylation,GO:0070887~cellular response to chemical stimulus,GO:0070640~vitamin D3 metabolic process,GO:0055114~oxidation-reduction process,GO:0046173~polyol biosynthetic process,GO:0046165~alcohol biosynthetic process,GO:0044712~single-organism catabolic process,GO:0044283~small molecule biosynthetic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044255~cellular lipid metabolic process,GO:0044248~cellular catabolic process,GO:0044108~cellular alcohol biosynthetic process,GO:0044107~cellular alcohol metabolic process,GO:0042738~exogenous drug catabolic process,GO:0042737~drug catabolic process,GO:0042493~response to drug,GO:0042445~hormone metabolic process,GO:0042368~vitamin D biosynthetic process,GO:0042362~fat-soluble vitamin biosynthetic process,GO:0042359~vitamin D metabolic process,GO:0036378~calcitriol biosynthetic process from calciol,GO:0034754~cellular hormone metabolic process,GO:0030258~lipid modification,GO:0019751~polyol metabolic process,GO:0017144~drug metabolic process,GO:0016098~monoterpenoid metabolic process,GO:0016042~lipid catabolic process,GO:0010817~regulation of hormone levels,GO:0009822~alkaloid catabolic process,GO:0009820~alkaloid metabolic process,GO:0009410~response to xenobiotic stimulus,GO:0009110~vitamin biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0008209~androgen metabolic process,GO:0008202~steroid metabolic process,GO:0006805~xenobiotic metabolic process,GO:0006775~fat-soluble vitamin metabolic process,GO:0006766~vitamin metabolic process,GO:0006721~terpenoid metabolic process,GO:0006720~isoprenoid metabolic process,GO:0006706~steroid catabolic process,GO:0006694~steroid biosynthetic process,GO:0006629~lipid metabolic process,GO:0006066~alcohol metabolic process,GO:0002933~lipid hydroxylation,											GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0070643~vitamin D 25-hydroxylase activity,GO:0070576~vitamin D 24-hydroxylase activity,GO:0070330~aromatase activity,GO:0050649~testosterone 6-beta-hydroxylase activity,GO:0050591~quinine 3-monooxygenase activity,GO:0047638~albendazole monooxygenase activity,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0034875~caffeine oxidase activity,GO:0033780~taurochenodeoxycholate 6alpha-hydroxylase activity,GO:0033695~oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,GO:0030343~vitamin D3 25-hydroxylase activity,GO:0020037~heme binding,GO:0019899~enzyme binding,GO:0019825~oxygen binding,GO:0016725~oxidoreductase activity, acting on CH or CH2 groups,GO:0016712~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,GO:0016705~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,GO:0008395~steroid hydroxylase activity,GO:0008289~lipid binding,GO:0005506~iron ion binding,GO:0005496~steroid binding,GO:0004497~monooxygenase activity,						IPR017972:Cytochrome P450, conserved site,IPR008072:Cytochrome P450, E-class, CYP3A,IPR002402:Cytochrome P450, E-class, group II,IPR002401:Cytochrome P450, E-class, group I,IPR001128:Cytochrome P450,																			hsa05204:Chemical carcinogenesis,hsa01100:Metabolic pathways,hsa00983:Drug metabolism - other enzymes,hsa00982:Drug metabolism - cytochrome P450,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00830:Retinol metabolism,hsa00591:Linoleic acid metabolism,hsa00140:Steroid hormone biosynthesis,						turn,transmembrane region,strand,sequence variant,sequence conflict,metal ion-binding site:Iron (heme axial ligand),helix,chain:Cytochrome P450 3A4,									
245937	defensin beta 124(DEFB124)	Homo sapiens						GO:0098542~defense response to other organism,GO:0051707~response to other organism,GO:0045087~innate immune response,GO:0043207~response to external biotic stimulus,GO:0042742~defense response to bacterium,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0006955~immune response,GO:0006952~defense response,											GO:0009986~cell surface,GO:0005576~extracellular region,									IPR025933:Beta-defensin,													signal peptide,disulfide bond,chain:Beta-defensin 124,									
8447	double C2 domain beta(DOC2B)	Homo sapiens						GO:1904951~positive regulation of establishment of protein localization,GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1903307~positive regulation of regulated secretory pathway,GO:1903305~regulation of regulated secretory pathway,GO:1902589~single-organism organelle organization,GO:1902580~single-organism cellular localization,GO:0099643~signal release from synapse,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0099531~presynaptic process involved in chemical synaptic transmission,GO:0099504~synaptic vesicle cycle,GO:0099003~vesicle mediated transport in synapse,GO:0098916~anterograde trans-synaptic signaling,GO:0097480~establishment of synaptic vesicle localization,GO:0097479~synaptic vesicle localization,GO:0090277~positive regulation of peptide hormone secretion,GO:0090276~regulation of peptide hormone secretion,GO:0090174~organelle membrane fusion,GO:0090087~regulation of peptide transport,GO:0071705~nitrogen compound transport,GO:0070201~regulation of establishment of protein localization,GO:0061025~membrane fusion,GO:0061024~membrane organization,GO:0060627~regulation of vesicle-mediated transport,GO:0051656~establishment of organelle localization,GO:0051650~establishment of vesicle localization,GO:0051649~establishment of localization in cell,GO:0051648~vesicle localization,GO:0051641~cellular localization,GO:0051640~organelle localization,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050796~regulation of insulin secretion,GO:0050714~positive regulation of protein secretion,GO:0050708~regulation of protein secretion,GO:0048791~calcium ion-regulated exocytosis of neurotransmitter,GO:0048489~synaptic vesicle transport,GO:0048284~organelle fusion,GO:0046903~secretion,GO:0046887~positive regulation of hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0045956~positive regulation of calcium ion-dependent exocytosis,GO:0045921~positive regulation of exocytosis,GO:0045184~establishment of protein localization,GO:0045055~regulated exocytosis,GO:0044802~single-organism membrane organization,GO:0044801~single-organism membrane fusion,GO:0042886~amide transport,GO:0033043~regulation of organelle organization,GO:0033036~macromolecule localization,GO:0032940~secretion by cell,GO:0032880~regulation of protein localization,GO:0032024~positive regulation of insulin secretion,GO:0031340~positive regulation of vesicle fusion,GO:0031338~regulation of vesicle fusion,GO:0030073~insulin secretion,GO:0030072~peptide hormone secretion,GO:0023061~signal release,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0017158~regulation of calcium ion-dependent exocytosis,GO:0017157~regulation of exocytosis,GO:0017156~calcium ion regulated exocytosis,GO:0016192~vesicle-mediated transport,GO:0016079~synaptic vesicle exocytosis,GO:0016050~vesicle organization,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0010817~regulation of hormone levels,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010638~positive regulation of organelle organization,GO:0009914~hormone transport,GO:0009306~protein secretion,GO:0008104~protein localization,GO:0007269~neurotransmitter secretion,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0006906~vesicle fusion,GO:0006887~exocytosis,GO:0006836~neurotransmitter transport,GO:0002793~positive regulation of peptide secretion,GO:0002791~regulation of peptide secretion,GO:0002790~peptide secretion,GO:0001505~regulation of neurotransmitter levels,											GO:0098793~presynapse,GO:0097458~neuron part,GO:0045202~synapse,GO:0044456~synapse part,GO:0031201~SNARE complex,															GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0030276~clathrin binding,GO:0019905~syntaxin binding,GO:0008289~lipid binding,GO:0005544~calcium-dependent phospholipid binding,GO:0005543~phospholipid binding,GO:0005509~calcium ion binding,GO:0000149~SNARE binding,						IPR014638:Double C2 protein, alpha/beta/gamma type,IPR001565:Synaptotagmin,IPR000008:C2 calcium-dependent membrane targeting,											PIRSF036931:double C2 protein, alpha/beta/gamma types,																						SM00239:C2,				domain:C2 2,domain:C2 1,chain:Double C2-like domain-containing protein beta,									
149647	family with sequence similarity 71 member A(FAM71A)	Homo sapiens		IPR022168:Protein of unknown function DUF3699,													sequence variant,compositionally biased region:Ala-rich,chain:Protein FAM71A,									
83888	fibroblast growth factor binding protein 2(FGFBP2)	Homo sapiens					GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0019838~growth factor binding,						IPR010510:FGF binding 1,													signal peptide,sequence variant,disulfide bond,chain:Fibroblast growth factor-binding protein 2,									
2922	gastrin releasing peptide(GRP)	Homo sapiens						GO:0007218~neuropeptide signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,											GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0005184~neuropeptide hormone activity,GO:0005179~hormone activity,GO:0005102~receptor binding,						IPR015674:Gastrin releasing peptide,IPR000874:Bombesin/neuromedin-B/ranatensin peptide family,													splice variant,signal peptide,sequence variant,peptide:Neuromedin-C,peptide:Gastrin-releasing peptide,modified residue,									
51738	ghrelin and obestatin prepropeptide(GHRL)	Homo sapiens										h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis,								GO:2000851~positive regulation of glucocorticoid secretion,GO:2000849~regulation of glucocorticoid secretion,GO:2000848~positive regulation of corticosteroid hormone secretion,GO:2000846~regulation of corticosteroid hormone secretion,GO:2000833~positive regulation of steroid hormone secretion,GO:2000831~regulation of steroid hormone secretion,GO:2000507~positive regulation of energy homeostasis,GO:2000506~negative regulation of energy homeostasis,GO:2000505~regulation of energy homeostasis,GO:2000181~negative regulation of blood vessel morphogenesis,GO:2000026~regulation of multicellular organismal development,GO:1905114~cell surface receptor signaling pathway involved in cell-cell signaling,GO:1904951~positive regulation of establishment of protein localization,GO:1904950~negative regulation of establishment of protein localization,GO:1903556~negative regulation of tumor necrosis factor superfamily cytokine production,GO:1903555~regulation of tumor necrosis factor superfamily cytokine production,GO:1903532~positive regulation of secretion by cell,GO:1903531~negative regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1902589~single-organism organelle organization,GO:1902533~positive regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:1901699~cellular response to nitrogen compound,GO:1901698~response to nitrogen compound,GO:1901653~cellular response to peptide,GO:1901652~response to peptide,GO:1901343~negative regulation of vasculature development,GO:1901342~regulation of vasculature development,GO:0099565~chemical synaptic transmission, postsynaptic,GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0098771~inorganic ion homeostasis,GO:0097009~energy homeostasis,GO:0090278~negative regulation of peptide hormone secretion,GO:0090277~positive regulation of peptide hormone secretion,GO:0090276~regulation of peptide hormone secretion,GO:0090087~regulation of peptide transport,GO:0080134~regulation of response to stress,GO:0072507~divalent inorganic cation homeostasis,GO:0072503~cellular divalent inorganic cation homeostasis,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0071902~positive regulation of protein serine/threonine kinase activity,GO:0071900~regulation of protein serine/threonine kinase activity,GO:0071706~tumor necrosis factor superfamily cytokine production,GO:0071705~nitrogen compound transport,GO:0071495~cellular response to endogenous stimulus,GO:0071417~cellular response to organonitrogen compound,GO:0071378~cellular response to growth hormone stimulus,GO:0071375~cellular response to peptide hormone stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070201~regulation of establishment of protein localization,GO:0065009~regulation of molecular function,GO:0061458~reproductive system development,GO:0061448~connective tissue development,GO:0061098~positive regulation of protein tyrosine kinase activity,GO:0061097~regulation of protein tyrosine kinase activity,GO:0060986~endocrine hormone secretion,GO:0060548~negative regulation of cell death,GO:0060416~response to growth hormone,GO:0060399~positive regulation of growth hormone receptor signaling pathway,GO:0060398~regulation of growth hormone receptor signaling pathway,GO:0060396~growth hormone receptor signaling pathway,GO:0060135~maternal process involved in female pregnancy,GO:0060124~positive regulation of growth hormone secretion,GO:0060123~regulation of growth hormone secretion,GO:0060079~excitatory postsynaptic potential,GO:0060078~regulation of postsynaptic membrane potential,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055074~calcium ion homeostasis,GO:0055065~metal ion homeostasis,GO:0051965~positive regulation of synapse assembly,GO:0051963~regulation of synapse assembly,GO:0051962~positive regulation of nervous system development,GO:0051960~regulation of nervous system development,GO:0051480~regulation of cytosolic calcium ion concentration,GO:0051464~positive regulation of cortisol secretion,GO:0051462~regulation of cortisol secretion,GO:0051461~positive regulation of corticotropin secretion,GO:0051459~regulation of corticotropin secretion,GO:0051458~corticotropin secretion,GO:0051347~positive regulation of transferase activity,GO:0051338~regulation of transferase activity,GO:0051248~negative regulation of protein metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051224~negative regulation of protein transport,GO:0051223~regulation of protein transport,GO:0051222~positive regulation of protein transport,GO:0051216~cartilage development,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051093~negative regulation of developmental process,GO:0051051~negative regulation of transport,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051048~negative regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050886~endocrine process,GO:0050808~synapse organization,GO:0050807~regulation of synapse organization,GO:0050803~regulation of synapse structure or activity,GO:0050802~circadian sleep/wake cycle, sleep,GO:0050801~ion homeostasis,GO:0050796~regulation of insulin secretion,GO:0050795~regulation of behavior,GO:0050790~regulation of catalytic activity,GO:0050731~positive regulation of peptidyl-tyrosine phosphorylation,GO:0050730~regulation of peptidyl-tyrosine phosphorylation,GO:0050728~negative regulation of inflammatory response,GO:0050727~regulation of inflammatory response,GO:0050714~positive regulation of protein secretion,GO:0050709~negative regulation of protein secretion,GO:0050708~regulation of protein secretion,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048878~chemical homeostasis,GO:0048871~multicellular organismal homeostasis,GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048646~anatomical structure formation involved in morphogenesis,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048609~multicellular organismal reproductive process,GO:0048608~reproductive structure development,GO:0048589~developmental growth,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048521~negative regulation of behavior,GO:0048520~positive regulation of behavior,GO:0048514~blood vessel morphogenesis,GO:0048512~circadian behavior,GO:0048511~rhythmic process,GO:0048468~cell development,GO:0046903~secretion,GO:0046888~negative regulation of hormone secretion,GO:0046887~positive regulation of hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0046717~acid secretion,GO:0046697~decidualization,GO:0046676~negative regulation of insulin secretion,GO:0046010~positive regulation of circadian sleep/wake cycle, non-REM sleep,GO:0045938~positive regulation of circadian sleep/wake cycle, sleep,GO:0045937~positive regulation of phosphate metabolic process,GO:0045927~positive regulation of growth,GO:0045860~positive regulation of protein kinase activity,GO:0045859~regulation of protein kinase activity,GO:0045765~regulation of angiogenesis,GO:0045409~negative regulation of interleukin-6 biosynthetic process,GO:0045408~regulation of interleukin-6 biosynthetic process,GO:0045188~regulation of circadian sleep/wake cycle, non-REM sleep,GO:0045187~regulation of circadian sleep/wake cycle, sleep,GO:0045184~establishment of protein localization,GO:0044723~single-organism carbohydrate metabolic process,GO:0044708~single-organism behavior,GO:0044706~multi-multicellular organism process,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044093~positive regulation of molecular function,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0044060~regulation of endocrine process,GO:0044057~regulation of system process,GO:0043627~response to estrogen,GO:0043549~regulation of kinase activity,GO:0043434~response to peptide hormone,GO:0043410~positive regulation of MAPK cascade,GO:0043408~regulation of MAPK cascade,GO:0043406~positive regulation of MAP kinase activity,GO:0043405~regulation of MAP kinase activity,GO:0043400~cortisol secretion,GO:0043085~positive regulation of catalytic activity,GO:0043069~negative regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043066~negative regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042886~amide transport,GO:0042754~negative regulation of circadian rhythm,GO:0042753~positive regulation of circadian rhythm,GO:0042752~regulation of circadian rhythm,GO:0042749~regulation of circadian sleep/wake cycle,GO:0042748~circadian sleep/wake cycle, non-REM sleep,GO:0042747~circadian sleep/wake cycle, REM sleep,GO:0042745~circadian sleep/wake cycle,GO:0042592~homeostatic process,GO:0042536~negative regulation of tumor necrosis factor biosynthetic process,GO:0042534~regulation of tumor necrosis factor biosynthetic process,GO:0042533~tumor necrosis factor biosynthetic process,GO:0042391~regulation of membrane potential,GO:0042327~positive regulation of phosphorylation,GO:0042325~regulation of phosphorylation,GO:0042322~negative regulation of circadian sleep/wake cycle, REM sleep,GO:0042321~negative regulation of circadian sleep/wake cycle, sleep,GO:0042320~regulation of circadian sleep/wake cycle, REM sleep,GO:0042226~interleukin-6 biosynthetic process,GO:0042127~regulation of cell proliferation,GO:0042107~cytokine metabolic process,GO:0042089~cytokine biosynthetic process,GO:0042036~negative regulation of cytokine biosynthetic process,GO:0042035~regulation of cytokine biosynthetic process,GO:0040018~positive regulation of multicellular organism growth,GO:0040014~regulation of multicellular organism growth,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0040008~regulation of growth,GO:0040007~growth,GO:0036211~protein modification process,GO:0035933~glucocorticoid secretion,GO:0035930~corticosteroid hormone secretion,GO:0035929~steroid hormone secretion,GO:0035556~intracellular signal transduction,GO:0035264~multicellular organism growth,GO:0033674~positive regulation of kinase activity,GO:0033036~macromolecule localization,GO:0032940~secretion by cell,GO:0032880~regulation of protein localization,GO:0032870~cellular response to hormone stimulus,GO:0032846~positive regulation of homeostatic process,GO:0032845~negative regulation of homeostatic process,GO:0032844~regulation of homeostatic process,GO:0032720~negative regulation of tumor necrosis factor production,GO:0032715~negative regulation of interleukin-6 production,GO:0032692~negative regulation of interleukin-1 production,GO:0032691~negative regulation of interleukin-1 beta production,GO:0032680~regulation of tumor necrosis factor production,GO:0032675~regulation of interleukin-6 production,GO:0032652~regulation of interleukin-1 production,GO:0032651~regulation of interleukin-1 beta production,GO:0032640~tumor necrosis factor production,GO:0032635~interleukin-6 production,GO:0032612~interleukin-1 production,GO:0032611~interleukin-1 beta production,GO:0032504~multicellular organism reproduction,GO:0032370~positive regulation of lipid transport,GO:0032368~regulation of lipid transport,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0032147~activation of protein kinase activity,GO:0032109~positive regulation of response to nutrient levels,GO:0032107~regulation of response to nutrient levels,GO:0032106~positive regulation of response to extracellular stimulus,GO:0032104~regulation of response to extracellular stimulus,GO:0032103~positive regulation of response to external stimulus,GO:0032102~negative regulation of response to external stimulus,GO:0032101~regulation of response to external stimulus,GO:0032100~positive regulation of appetite,GO:0032098~regulation of appetite,GO:0032097~positive regulation of response to food,GO:0032095~regulation of response to food,GO:0032094~response to food,GO:0032024~positive regulation of insulin secretion,GO:0031667~response to nutrient levels,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031348~negative regulation of defense response,GO:0031347~regulation of defense response,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031175~neuron projection development,GO:0030534~adult behavior,GO:0030431~sleep,GO:0030252~growth hormone secretion,GO:0030182~neuron differentiation,GO:0030073~insulin secretion,GO:0030072~peptide hormone secretion,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0030003~cellular cation homeostasis,GO:0023061~signal release,GO:0023057~negative regulation of signaling,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0023014~signal transduction by protein phosphorylation,GO:0022607~cellular component assembly,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022600~digestive system process,GO:0022414~reproductive process,GO:0022410~circadian sleep/wake cycle process,GO:0022008~neurogenesis,GO:0019725~cellular homeostasis,GO:0019318~hexose metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0018212~peptidyl-tyrosine modification,GO:0018193~peptidyl-amino acid modification,GO:0018108~peptidyl-tyrosine phosphorylation,GO:0016525~negative regulation of angiogenesis,GO:0016358~dendrite development,GO:0016310~phosphorylation,GO:0015850~organic hydroxy compound transport,GO:0015833~peptide transport,GO:0015031~protein transport,GO:0012501~programmed cell death,GO:0010941~regulation of cell death,GO:0010876~lipid localization,GO:0010817~regulation of hormone levels,GO:0010648~negative regulation of cell communication,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010243~response to organonitrogen compound,GO:0010033~response to organic substance,GO:0009991~response to extracellular stimulus,GO:0009967~positive regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009914~hormone transport,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009755~hormone-mediated signaling pathway,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0009605~response to external stimulus,GO:0009306~protein secretion,GO:0008343~adult feeding behavior,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0008154~actin polymerization or depolymerization,GO:0008104~protein localization,GO:0007631~feeding behavior,GO:0007623~circadian rhythm,GO:0007622~rhythmic behavior,GO:0007610~behavior,GO:0007586~digestion,GO:0007565~female pregnancy,GO:0007416~synapse assembly,GO:0007399~nervous system development,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007204~positive regulation of cytosolic calcium ion concentration,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007167~enzyme linked receptor protein signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0006954~inflammatory response,GO:0006952~defense response,GO:0006915~apoptotic process,GO:0006875~cellular metal ion homeostasis,GO:0006874~cellular calcium ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006869~lipid transport,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0006006~glucose metabolic process,GO:0005996~monosaccharide metabolic process,GO:0005975~carbohydrate metabolic process,GO:0003008~system process,GO:0003006~developmental process involved in reproduction,GO:0002793~positive regulation of peptide secretion,GO:0002792~negative regulation of peptide secretion,GO:0002791~regulation of peptide secretion,GO:0002790~peptide secretion,GO:0001944~vasculature development,GO:0001937~negative regulation of endothelial cell proliferation,GO:0001936~regulation of endothelial cell proliferation,GO:0001935~endothelial cell proliferation,GO:0001934~positive regulation of protein phosphorylation,GO:0001932~regulation of protein phosphorylation,GO:0001893~maternal placenta development,GO:0001890~placenta development,GO:0001818~negative regulation of cytokine production,GO:0001817~regulation of cytokine production,GO:0001816~cytokine production,GO:0001696~gastric acid secretion,GO:0001568~blood vessel development,GO:0001525~angiogenesis,GO:0001501~skeletal system development,GO:0000187~activation of MAPK activity,GO:0000165~MAPK cascade,GO:0000003~reproduction,											GO:0099503~secretory vesicle,GO:0098794~postsynapse,GO:0097458~neuron part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0045202~synapse,GO:0044456~synapse part,GO:0044433~cytoplasmic vesicle part,GO:0044432~endoplasmic reticulum part,GO:0044421~extracellular region part,GO:0043005~neuron projection,GO:0034774~secretory granule lumen,GO:0031988~membrane-bounded vesicle,GO:0031983~vesicle lumen,GO:0030424~axon,GO:0030141~secretory granule,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0005788~endoplasmic reticulum lumen,GO:0005783~endoplasmic reticulum,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0098772~molecular function regulator,GO:0031768~ghrelin receptor binding,GO:0030296~protein tyrosine kinase activator activity,GO:0030295~protein kinase activator activity,GO:0030234~enzyme regulator activity,GO:0019887~protein kinase regulator activity,GO:0019209~kinase activator activity,GO:0019207~kinase regulator activity,GO:0016608~growth hormone-releasing hormone activity,GO:0008047~enzyme activator activity,GO:0005179~hormone activity,GO:0005102~receptor binding,GO:0001664~G-protein coupled receptor binding,						IPR006738:Motilin/ghrelin,IPR006737:Motilin/ghrelin-associated peptide,IPR005441:Preproghrelin peptide,																			hsa04024:cAMP signaling pathway,							601665~Obesity, susceptibility to,											strand,splice variant,signal peptide,sequence variant,propeptide:Removed in mature form,peptide:Obestatin,peptide:Ghrelin-28,peptide:Ghrelin-27,modified residue,lipid moiety-binding region:O-octanoyl serine; alternate,lipid moiety-binding region:O-decanoyl serine; alternate,helix,									
2940	glutathione S-transferase alpha 3(GSTA3)	Homo sapiens						GO:1901687~glutathione derivative biosynthetic process,GO:1901685~glutathione derivative metabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:0044272~sulfur compound biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0006790~sulfur compound metabolic process,GO:0006749~glutathione metabolic process,GO:0006575~cellular modified amino acid metabolic process,GO:0006518~peptide metabolic process,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0005829~cytosol,GO:0005576~extracellular region,															GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,GO:0004364~glutathione transferase activity,						IPR012336:Thioredoxin-like fold,IPR010987:Glutathione S-transferase, C-terminal-like,IPR004046:Glutathione S-transferase, C-terminal,IPR004045:Glutathione S-transferase, N-terminal,IPR003080:Glutathione S-transferase, alpha class,																			hsa05204:Chemical carcinogenesis,hsa00982:Drug metabolism - cytochrome P450,hsa00980:Metabolism of xenobiotics by cytochrome P450,hsa00480:Glutathione metabolism,						turn,strand,sequence variant,sequence conflict,helix,domain:GST N-terminal,domain:GST C-terminal,chain:Glutathione S-transferase A3,									
27306	hematopoietic prostaglandin D synthase(HPGDS)	Homo sapiens										h_eicosanoidPathway:Eicosanoid Metabolism,								GO:2000255~negative regulation of male germ cell proliferation,GO:2000254~regulation of male germ cell proliferation,GO:2000242~negative regulation of reproductive process,GO:2000241~regulation of reproductive process,GO:1901687~glutathione derivative biosynthetic process,GO:1901685~glutathione derivative metabolic process,GO:1901566~organonitrogen compound biosynthetic process,GO:0072330~monocarboxylic acid biosynthetic process,GO:0051241~negative regulation of multicellular organismal process,GO:0048609~multicellular organismal reproductive process,GO:0046457~prostanoid biosynthetic process,GO:0046456~icosanoid biosynthetic process,GO:0046394~carboxylic acid biosynthetic process,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044283~small molecule biosynthetic process,GO:0044272~sulfur compound biosynthetic process,GO:0044255~cellular lipid metabolic process,GO:0043901~negative regulation of multi-organism process,GO:0043900~regulation of multi-organism process,GO:0043436~oxoacid metabolic process,GO:0042127~regulation of cell proliferation,GO:0036093~germ cell proliferation,GO:0033559~unsaturated fatty acid metabolic process,GO:0032787~monocarboxylic acid metabolic process,GO:0032504~multicellular organism reproduction,GO:0022414~reproductive process,GO:0019953~sexual reproduction,GO:0019752~carboxylic acid metabolic process,GO:0019371~cyclooxygenase pathway,GO:0019369~arachidonic acid metabolic process,GO:0016053~organic acid biosynthetic process,GO:0008610~lipid biosynthetic process,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007276~gamete generation,GO:0006790~sulfur compound metabolic process,GO:0006693~prostaglandin metabolic process,GO:0006692~prostanoid metabolic process,GO:0006690~icosanoid metabolic process,GO:0006636~unsaturated fatty acid biosynthetic process,GO:0006633~fatty acid biosynthetic process,GO:0006631~fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006082~organic acid metabolic process,GO:0002176~male germ cell proliferation,GO:0001676~long-chain fatty acid metabolic process,GO:0001516~prostaglandin biosynthetic process,GO:0000003~reproduction,											GO:0005829~cytosol,															GO:0046983~protein dimerization activity,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0016860~intramolecular oxidoreductase activity,GO:0016853~isomerase activity,GO:0016765~transferase activity, transferring alkyl or aryl (other than methyl) groups,GO:0005509~calcium ion binding,GO:0004667~prostaglandin-D synthase activity,GO:0004364~glutathione transferase activity,GO:0000287~magnesium ion binding,						IPR012336:Thioredoxin-like fold,IPR010987:Glutathione S-transferase, C-terminal-like,IPR004046:Glutathione S-transferase, C-terminal,IPR004045:Glutathione S-transferase, N-terminal,																			hsa01100:Metabolic pathways,hsa00590:Arachidonic acid metabolism,						turn,strand,signal peptide,sequence variant,sequence conflict,helix,glycosylation site:N-linked (GlcNAc...),domain:GST N-terminal,domain:GST C-terminal,disulfide bond,chain:Prostaglandin-H2 D-isomerase,chain:Hematopoietic prostaglandin D synthase,active site:Nucleophile,									
3039	hemoglobin subunit alpha 1(HBA1)	Homo sapiens										h_ahspPathway:Hemoglobin's Chaperone,								GO:1990748~cellular detoxification,GO:1901700~response to oxygen-containing compound,GO:0098869~cellular oxidant detoxification,GO:0098754~detoxification,GO:0072593~reactive oxygen species metabolic process,GO:0071822~protein complex subunit organization,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0051291~protein heterooligomerization,GO:0051259~protein oligomerization,GO:0044248~cellular catabolic process,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042542~response to hydrogen peroxide,GO:0022607~cellular component assembly,GO:0016192~vesicle-mediated transport,GO:0015711~organic anion transport,GO:0015701~bicarbonate transport,GO:0015671~oxygen transport,GO:0015669~gas transport,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010035~response to inorganic substance,GO:0009636~response to toxic substance,GO:0008219~cell death,GO:0006979~response to oxidative stress,GO:0006898~receptor-mediated endocytosis,GO:0006897~endocytosis,GO:0006820~anion transport,GO:0006811~ion transport,GO:0006461~protein complex assembly,GO:0000302~response to reactive oxygen species,											GO:1990904~ribonucleoprotein complex,GO:1903561~extracellular vesicle,GO:0072562~blood microparticle,GO:0071682~endocytic vesicle lumen,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0044445~cytosolic part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0044391~ribosomal subunit,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0031983~vesicle lumen,GO:0031838~haptoglobin-hemoglobin complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0030139~endocytic vesicle,GO:0022627~cytosolic small ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0015935~small ribosomal subunit,GO:0005840~ribosome,GO:0005833~hemoglobin complex,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0031720~haptoglobin binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0005506~iron ion binding,GO:0005344~oxygen transporter activity,GO:0004601~peroxidase activity,						IPR012292:Globin, structural domain,IPR009050:Globin-like,IPR002339:Haemoglobin, pi,IPR002338:Haemoglobin, alpha,IPR000971:Globin,																			hsa05144:Malaria,hsa05143:African trypanosomiasis,							Methemoglobinemias, alpha-~Methemoglobinemias, alpha-,Erythremias, alpha-~Erythremias, alpha-,613978~Hemoglobin H disease, nondeletional,604131~Thalassemias, alpha-,140700~Heinz body anemias, alpha-,											turn,site:Not glycated,sequence variant,sequence conflict,modified residue,metal ion-binding site:Iron (heme proximal ligand),metal ion-binding site:Iron (heme distal ligand),helix,glycosylation site:N-linked (Glc) (glycation),chain:Hemoglobin subunit alpha,									
3040	hemoglobin subunit alpha 2(HBA2)	Homo sapiens										h_ahspPathway:Hemoglobin's Chaperone,								GO:1990748~cellular detoxification,GO:1901700~response to oxygen-containing compound,GO:0098869~cellular oxidant detoxification,GO:0098754~detoxification,GO:0072593~reactive oxygen species metabolic process,GO:0071822~protein complex subunit organization,GO:0070271~protein complex biogenesis,GO:0065003~macromolecular complex assembly,GO:0051291~protein heterooligomerization,GO:0051259~protein oligomerization,GO:0044248~cellular catabolic process,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0042744~hydrogen peroxide catabolic process,GO:0042743~hydrogen peroxide metabolic process,GO:0042542~response to hydrogen peroxide,GO:0022607~cellular component assembly,GO:0016192~vesicle-mediated transport,GO:0015711~organic anion transport,GO:0015701~bicarbonate transport,GO:0015671~oxygen transport,GO:0015669~gas transport,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010035~response to inorganic substance,GO:0009636~response to toxic substance,GO:0008219~cell death,GO:0006979~response to oxidative stress,GO:0006898~receptor-mediated endocytosis,GO:0006897~endocytosis,GO:0006820~anion transport,GO:0006811~ion transport,GO:0006461~protein complex assembly,GO:0000302~response to reactive oxygen species,											GO:1990904~ribonucleoprotein complex,GO:1903561~extracellular vesicle,GO:0072562~blood microparticle,GO:0071682~endocytic vesicle lumen,GO:0070062~extracellular exosome,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0044445~cytosolic part,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0044391~ribosomal subunit,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0031983~vesicle lumen,GO:0031838~haptoglobin-hemoglobin complex,GO:0030529~intracellular ribonucleoprotein complex,GO:0030139~endocytic vesicle,GO:0022627~cytosolic small ribosomal subunit,GO:0022626~cytosolic ribosome,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0015935~small ribosomal subunit,GO:0005840~ribosome,GO:0005833~hemoglobin complex,GO:0005829~cytosol,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046914~transition metal ion binding,GO:0046906~tetrapyrrole binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0031720~haptoglobin binding,GO:0020037~heme binding,GO:0019825~oxygen binding,GO:0016684~oxidoreductase activity, acting on peroxide as acceptor,GO:0016209~antioxidant activity,GO:0005506~iron ion binding,GO:0005344~oxygen transporter activity,GO:0004601~peroxidase activity,						IPR012292:Globin, structural domain,IPR009050:Globin-like,IPR002339:Haemoglobin, pi,IPR002338:Haemoglobin, alpha,IPR000971:Globin,																			hsa05144:Malaria,hsa05143:African trypanosomiasis,							Hypochromic microcytic anemia~Hypochromic microcytic anemia,Erythrocytosis~Erythrocytosis,613978~Hemoglobin H disease, nondeletional,604131~Thalassemia, alpha-,140700~Heinz body anemia,											turn,site:Not glycated,sequence variant,sequence conflict,modified residue,metal ion-binding site:Iron (heme proximal ligand),metal ion-binding site:Iron (heme distal ligand),helix,glycosylation site:N-linked (Glc) (glycation),chain:Hemoglobin subunit alpha,									
57817	hepcidin antimicrobial peptide(HAMP)	Homo sapiens						GO:2001258~negative regulation of cation channel activity,GO:2001257~regulation of cation channel activity,GO:2001141~regulation of RNA biosynthetic process,GO:2000727~positive regulation of cardiac muscle cell differentiation,GO:2000725~regulation of cardiac muscle cell differentiation,GO:2000646~positive regulation of receptor catabolic process,GO:2000644~regulation of receptor catabolic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000026~regulation of multicellular organismal development,GO:1990641~response to iron ion starvation,GO:1990267~response to transition metal nanoparticle,GO:1905209~positive regulation of cardiocyte differentiation,GO:1905207~regulation of cardiocyte differentiation,GO:1904479~negative regulation of intestinal absorption,GO:1904478~regulation of intestinal absorption,GO:1904255~negative regulation of iron channel activity,GO:1904254~regulation of iron channel activity,GO:1904063~negative regulation of cation transmembrane transport,GO:1904062~regulation of cation transmembrane transport,GO:1904039~negative regulation of ferrous iron export,GO:1904038~regulation of ferrous iron export,GO:1903988~ferrous iron export,GO:1903874~ferrous iron transmembrane transport,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1903414~iron cation export,GO:1903413~cellular response to bile acid,GO:1903412~response to bile acid,GO:1903322~positive regulation of protein modification by small protein conjugation or removal,GO:1903320~regulation of protein modification by small protein conjugation or removal,GO:1902916~positive regulation of protein polyubiquitination,GO:1902914~regulation of protein polyubiquitination,GO:1902679~negative regulation of RNA biosynthetic process,GO:1901863~positive regulation of muscle tissue development,GO:1901861~regulation of muscle tissue development,GO:1901701~cellular response to oxygen-containing compound,GO:1901700~response to oxygen-containing compound,GO:0098771~inorganic ion homeostasis,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0098542~defense response to other organism,GO:0097659~nucleic acid-templated transcription,GO:0097421~liver regeneration,GO:0097305~response to alcohol,GO:0090257~regulation of muscle system process,GO:0072511~divalent inorganic cation transport,GO:0072359~circulatory system development,GO:0072358~cardiovascular system development,GO:0071481~cellular response to X-ray,GO:0071479~cellular response to ionizing radiation,GO:0071478~cellular response to radiation,GO:0071407~cellular response to organic cyclic compound,GO:0071396~cellular response to lipid,GO:0071356~cellular response to tumor necrosis factor,GO:0071354~cellular response to interleukin-6,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0071229~cellular response to acid chemical,GO:0071222~cellular response to lipopolysaccharide,GO:0071219~cellular response to molecule of bacterial origin,GO:0071216~cellular response to biotic stimulus,GO:0071214~cellular response to abiotic stimulus,GO:0070887~cellular response to chemical stimulus,GO:0070839~divalent metal ion export,GO:0070838~divalent metal ion transport,GO:0070741~response to interleukin-6,GO:0070647~protein modification by small protein conjugation or removal,GO:0065009~regulation of molecular function,GO:0061061~muscle structure development,GO:0061051~positive regulation of cell growth involved in cardiac muscle cell development,GO:0061050~regulation of cell growth involved in cardiac muscle cell development,GO:0061049~cell growth involved in cardiac muscle cell development,GO:0061008~hepaticobiliary system development,GO:0060627~regulation of vesicle-mediated transport,GO:0060586~multicellular organismal iron ion homeostasis,GO:0060537~muscle tissue development,GO:0060457~negative regulation of digestive system process,GO:0060421~positive regulation of heart growth,GO:0060420~regulation of heart growth,GO:0060419~heart growth,GO:0060284~regulation of cell development,GO:0055085~transmembrane transport,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055076~transition metal ion homeostasis,GO:0055072~iron ion homeostasis,GO:0055065~metal ion homeostasis,GO:0055025~positive regulation of cardiac muscle tissue development,GO:0055024~regulation of cardiac muscle tissue development,GO:0055023~positive regulation of cardiac muscle tissue growth,GO:0055021~regulation of cardiac muscle tissue growth,GO:0055017~cardiac muscle tissue growth,GO:0055013~cardiac muscle cell development,GO:0055007~cardiac muscle cell differentiation,GO:0055006~cardiac cell development,GO:0055002~striated muscle cell development,GO:0055001~muscle cell development,GO:0051707~response to other organism,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051247~positive regulation of protein metabolic process,GO:0051246~regulation of protein metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051155~positive regulation of striated muscle cell differentiation,GO:0051153~regulation of striated muscle cell differentiation,GO:0051149~positive regulation of muscle cell differentiation,GO:0051147~regulation of muscle cell differentiation,GO:0051146~striated muscle cell differentiation,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051094~positive regulation of developmental process,GO:0051051~negative regulation of transport,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0050892~intestinal absorption,GO:0050832~defense response to fungus,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0048871~multicellular organismal homeostasis,GO:0048738~cardiac muscle tissue development,GO:0048732~gland development,GO:0048639~positive regulation of developmental growth,GO:0048638~regulation of developmental growth,GO:0048636~positive regulation of muscle organ development,GO:0048634~regulation of muscle organ development,GO:0048589~developmental growth,GO:0048588~developmental cell growth,GO:0048468~cell development,GO:0048260~positive regulation of receptor-mediated endocytosis,GO:0048259~regulation of receptor-mediated endocytosis,GO:0046916~cellular transition metal ion homeostasis,GO:0046622~positive regulation of organ growth,GO:0046620~regulation of organ growth,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045927~positive regulation of growth,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045844~positive regulation of striated muscle tissue development,GO:0045807~positive regulation of endocytosis,GO:0045597~positive regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0045471~response to ethanol,GO:0044364~disruption of cells of other organism,GO:0044248~cellular catabolic process,GO:0044092~negative regulation of molecular function,GO:0044058~regulation of digestive system process,GO:0044057~regulation of system process,GO:0043502~regulation of muscle adaptation,GO:0043500~muscle adaptation,GO:0043271~negative regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043207~response to external biotic stimulus,GO:0043112~receptor metabolic process,GO:0042742~defense response to bacterium,GO:0042692~muscle cell differentiation,GO:0042594~response to starvation,GO:0042592~homeostatic process,GO:0040008~regulation of growth,GO:0040007~growth,GO:0036211~protein modification process,GO:0036017~response to erythropoietin,GO:0035821~modification of morphology or physiology of other organism,GO:0035265~organ growth,GO:0035051~cardiocyte differentiation,GO:0034766~negative regulation of ion transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0034763~negative regulation of transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034760~negative regulation of iron ion transmembrane transport,GO:0034759~regulation of iron ion transmembrane transport,GO:0034757~negative regulation of iron ion transport,GO:0034756~regulation of iron ion transport,GO:0034755~iron ion transmembrane transport,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034612~response to tumor necrosis factor,GO:0034220~ion transmembrane transport,GO:0034097~response to cytokine,GO:0033993~response to lipid,GO:0033273~response to vitamin,GO:0033189~response to vitamin A,GO:0032801~receptor catabolic process,GO:0032774~RNA biosynthetic process,GO:0032496~response to lipopolysaccharide,GO:0032446~protein modification by small protein conjugation,GO:0032413~negative regulation of ion transmembrane transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032410~negative regulation of transporter activity,GO:0032409~regulation of transporter activity,GO:0032270~positive regulation of cellular protein metabolic process,GO:0032268~regulation of cellular protein metabolic process,GO:0031667~response to nutrient levels,GO:0031640~killing of cells of other organism,GO:0031623~receptor internalization,GO:0031401~positive regulation of protein modification process,GO:0031399~regulation of protein modification process,GO:0031398~positive regulation of protein ubiquitination,GO:0031396~regulation of protein ubiquitination,GO:0031331~positive regulation of cellular catabolic process,GO:0031329~regulation of cellular catabolic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031100~organ regeneration,GO:0031099~regeneration,GO:0030307~positive regulation of cell growth,GO:0030100~regulation of endocytosis,GO:0030003~cellular cation homeostasis,GO:0030001~metal ion transport,GO:0022898~regulation of transmembrane transporter activity,GO:0022600~digestive system process,GO:0019725~cellular homeostasis,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016567~protein ubiquitination,GO:0016202~regulation of striated muscle tissue development,GO:0016192~vesicle-mediated transport,GO:0016070~RNA metabolic process,GO:0016049~cell growth,GO:0015684~ferrous iron transport,GO:0014897~striated muscle hypertrophy,GO:0014896~muscle hypertrophy,GO:0014743~regulation of muscle hypertrophy,GO:0014742~positive regulation of muscle hypertrophy,GO:0014706~striated muscle tissue development,GO:0014070~response to organic cyclic compound,GO:0010959~regulation of metal ion transport,GO:0010720~positive regulation of cell development,GO:0010629~negative regulation of gene expression,GO:0010613~positive regulation of cardiac muscle hypertrophy,GO:0010611~regulation of cardiac muscle hypertrophy,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010212~response to ionizing radiation,GO:0010165~response to X-ray,GO:0010043~response to zinc ion,GO:0010039~response to iron ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,GO:0010033~response to organic substance,GO:0009991~response to extracellular stimulus,GO:0009896~positive regulation of catabolic process,GO:0009894~regulation of catabolic process,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009628~response to abiotic stimulus,GO:0009620~response to fungus,GO:0009617~response to bacterium,GO:0009607~response to biotic stimulus,GO:0009605~response to external stimulus,GO:0009314~response to radiation,GO:0009057~macromolecule catabolic process,GO:0007586~digestion,GO:0007584~response to nutrient,GO:0007568~aging,GO:0007517~muscle organ development,GO:0007507~heart development,GO:0006955~immune response,GO:0006954~inflammatory response,GO:0006953~acute-phase response,GO:0006952~defense response,GO:0006898~receptor-mediated endocytosis,GO:0006897~endocytosis,GO:0006879~cellular iron ion homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006873~cellular ion homeostasis,GO:0006826~iron ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0006464~cellular protein modification process,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0003301~physiological cardiac muscle hypertrophy,GO:0003300~cardiac muscle hypertrophy,GO:0003298~physiological muscle hypertrophy,GO:0003012~muscle system process,GO:0003008~system process,GO:0002526~acute inflammatory response,GO:0002237~response to molecule of bacterial origin,GO:0002092~positive regulation of receptor internalization,GO:0002090~regulation of receptor internalization,GO:0001906~cell killing,GO:0001889~liver development,GO:0001558~regulation of cell growth,GO:0001101~response to acid chemical,GO:0000209~protein polyubiquitination,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0000041~transition metal ion transport,											GO:0099738~cell cortex region,GO:0099568~cytoplasmic region,GO:0045179~apical cortex,GO:0045177~apical part of cell,GO:0044448~cell cortex part,GO:0044421~extracellular region part,GO:0044291~cell-cell contact zone,GO:0030054~cell junction,GO:0014704~intercalated disc,GO:0005938~cell cortex,GO:0005911~cell-cell junction,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0098772~molecular function regulator,GO:0097690~iron channel inhibitor activity,GO:0016248~channel inhibitor activity,GO:0016247~channel regulator activity,GO:0008200~ion channel inhibitor activity,GO:0005179~hormone activity,GO:0005102~receptor binding,						IPR010500:Hepcidin,														613313~Hemochromatosis, type 2B,											strand,signal peptide,sequence variant,sequence conflict,peptide:Hepcidin-25,peptide:Hepcidin-20,disulfide bond,									
3010	histone cluster 1 H1 family member t(HIST1H1T)	Homo sapiens						GO:0071824~protein-DNA complex subunit organization,GO:0071822~protein complex subunit organization,GO:0071103~DNA conformation change,GO:0070271~protein complex biogenesis,GO:0065004~protein-DNA complex assembly,GO:0065003~macromolecular complex assembly,GO:0051276~chromosome organization,GO:0048609~multicellular organismal reproductive process,GO:0048232~male gamete generation,GO:0044703~multi-organism reproductive process,GO:0044702~single organism reproductive process,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0034728~nucleosome organization,GO:0034622~cellular macromolecular complex assembly,GO:0032504~multicellular organism reproduction,GO:0031497~chromatin assembly,GO:0022607~cellular component assembly,GO:0022414~reproductive process,GO:0019953~sexual reproduction,GO:0007283~spermatogenesis,GO:0007276~gamete generation,GO:0006461~protein complex assembly,GO:0006334~nucleosome assembly,GO:0006333~chromatin assembly or disassembly,GO:0006325~chromatin organization,GO:0006323~DNA packaging,GO:0000003~reproduction,											GO:0044815~DNA packaging complex,GO:0044427~chromosomal part,GO:0032993~protein-DNA complex,GO:0005694~chromosome,GO:0000786~nucleosome,GO:0000785~chromatin,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,						IPR011991:Winged helix-turn-helix DNA-binding domain,IPR005819:Histone H5,IPR005818:Histone H1/H5,																					SM00526:H15,				sequence variant,region of interest:Globular,modified residue,chain:Histone H1t,									
8335	histone cluster 1 H2A family member b(HIST1H2AB)	Homo sapiens						GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0051276~chromosome organization,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045814~negative regulation of gene expression, epigenetic,GO:0043933~macromolecular complex subunit organization,GO:0042127~regulation of cell proliferation,GO:0040029~regulation of gene expression, epigenetic,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0032774~RNA biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016458~gene silencing,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0006342~chromatin silencing,GO:0006325~chromatin organization,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044815~DNA packaging complex,GO:0044454~nuclear chromosome part,GO:0044427~chromosomal part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0032993~protein-DNA complex,GO:0031988~membrane-bounded vesicle,GO:0005694~chromosome,GO:0005576~extracellular region,GO:0000790~nuclear chromatin,GO:0000786~nucleosome,GO:0000785~chromatin,GO:0000228~nuclear chromosome,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,						IPR009072:Histone-fold,IPR007125:Histone core,IPR002119:Histone H2A,																			hsa05322:Systemic lupus erythematosus,hsa05034:Alcoholism,														SM00414:H2A,				turn,strand,sequence conflict,mutagenesis site,modified residue,helix,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),chain:Histone H2A type 1-B/E,									
3018	histone cluster 1 H2B family member b(HIST1H2BB)	Homo sapiens						GO:0071824~protein-DNA complex subunit organization,GO:0071822~protein complex subunit organization,GO:0071103~DNA conformation change,GO:0070271~protein complex biogenesis,GO:0065004~protein-DNA complex assembly,GO:0065003~macromolecular complex assembly,GO:0051276~chromosome organization,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0034728~nucleosome organization,GO:0034622~cellular macromolecular complex assembly,GO:0031497~chromatin assembly,GO:0022607~cellular component assembly,GO:0006461~protein complex assembly,GO:0006334~nucleosome assembly,GO:0006333~chromatin assembly or disassembly,GO:0006325~chromatin organization,GO:0006323~DNA packaging,											GO:0098687~chromosomal region,GO:0044815~DNA packaging complex,GO:0044454~nuclear chromosome part,GO:0044427~chromosomal part,GO:0032993~protein-DNA complex,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0000790~nuclear chromatin,GO:0000788~nuclear nucleosome,GO:0000786~nucleosome,GO:0000785~chromatin,GO:0000784~nuclear chromosome, telomeric region,GO:0000781~chromosome, telomeric region,GO:0000228~nuclear chromosome,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,						IPR009072:Histone-fold,IPR007125:Histone core,IPR000558:Histone H2B,																			hsa05322:Systemic lupus erythematosus,hsa05203:Viral carcinogenesis,hsa05034:Alcoholism,														SM00427:H2B,				modified residue,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin),chain:Histone H2B type 1-B,									
121504	histone cluster 4 H4(HIST4H4)	Homo sapiens						GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:2000026~regulation of multicellular organismal development,GO:1904837~beta-catenin-TCF complex assembly,GO:1903707~negative regulation of hemopoiesis,GO:1903706~regulation of hemopoiesis,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0071824~protein-DNA complex subunit organization,GO:0071822~protein complex subunit organization,GO:0071103~DNA conformation change,GO:0070271~protein complex biogenesis,GO:0065004~protein-DNA complex assembly,GO:0065003~macromolecular complex assembly,GO:0061641~CENP-A containing chromatin organization,GO:0060249~anatomical structure homeostasis,GO:0051291~protein heterooligomerization,GO:0051290~protein heterotetramerization,GO:0051276~chromosome organization,GO:0051262~protein tetramerization,GO:0051259~protein oligomerization,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051093~negative regulation of developmental process,GO:0048534~hematopoietic or lymphoid organ development,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045815~positive regulation of gene expression, epigenetic,GO:0045814~negative regulation of gene expression, epigenetic,GO:0045653~negative regulation of megakaryocyte differentiation,GO:0045652~regulation of megakaryocyte differentiation,GO:0045638~negative regulation of myeloid cell differentiation,GO:0045637~regulation of myeloid cell differentiation,GO:0045596~negative regulation of cell differentiation,GO:0045595~regulation of cell differentiation,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043486~histone exchange,GO:0043044~ATP-dependent chromatin remodeling,GO:0042592~homeostatic process,GO:0040029~regulation of gene expression, epigenetic,GO:0034728~nucleosome organization,GO:0034724~DNA replication-independent nucleosome organization,GO:0034723~DNA replication-dependent nucleosome organization,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0034622~cellular macromolecular complex assembly,GO:0034508~centromere complex assembly,GO:0034080~CENP-A containing nucleosome assembly,GO:0033554~cellular response to stress,GO:0032774~RNA biosynthetic process,GO:0032200~telomere organization,GO:0031497~chromatin assembly,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031324~negative regulation of cellular metabolic process,GO:0031055~chromatin remodeling at centromere,GO:0031047~gene silencing by RNA,GO:0030219~megakaryocyte differentiation,GO:0030099~myeloid cell differentiation,GO:0030097~hemopoiesis,GO:0022607~cellular component assembly,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016458~gene silencing,GO:0016233~telomere capping,GO:0016070~RNA metabolic process,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0006974~cellular response to DNA damage stimulus,GO:0006461~protein complex assembly,GO:0006355~regulation of transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006351~transcription, DNA-templated,GO:0006342~chromatin silencing,GO:0006338~chromatin remodeling,GO:0006336~DNA replication-independent nucleosome assembly,GO:0006335~DNA replication-dependent nucleosome assembly,GO:0006334~nucleosome assembly,GO:0006333~chromatin assembly or disassembly,GO:0006325~chromatin organization,GO:0006323~DNA packaging,GO:0006303~double-strand break repair via nonhomologous end joining,GO:0006302~double-strand break repair,GO:0006281~DNA repair,GO:0006259~DNA metabolic process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002520~immune system development,GO:0000726~non-recombinational repair,GO:0000723~telomere maintenance,GO:0000183~chromatin silencing at rDNA,											GO:1903561~extracellular vesicle,GO:0098687~chromosomal region,GO:0070062~extracellular exosome,GO:0044815~DNA packaging complex,GO:0044454~nuclear chromosome part,GO:0044427~chromosomal part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0032993~protein-DNA complex,GO:0031988~membrane-bounded vesicle,GO:0031012~extracellular matrix,GO:0005694~chromosome,GO:0005654~nucleoplasm,GO:0005576~extracellular region,GO:0000786~nucleosome,GO:0000785~chromatin,GO:0000784~nuclear chromosome, telomeric region,GO:0000781~chromosome, telomeric region,GO:0000228~nuclear chromosome,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0046983~protein dimerization activity,GO:0046982~protein heterodimerization activity,GO:0044822~poly(A) RNA binding,GO:0042393~histone binding,GO:0019904~protein domain specific binding,GO:0003723~RNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,						IPR019809:Histone H4, conserved site,IPR009072:Histone-fold,IPR004823:TATA box binding protein associated factor (TAF),IPR001951:Histone H4,																			hsa05322:Systemic lupus erythematosus,hsa05203:Viral carcinogenesis,hsa05034:Alcoholism,														SM00803:TAF,SM00417:H4,				strand,sequence variant,sequence conflict,modified residue,helix,cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin); alternate,chain:Histone H4,									
51179	hydroxyacid oxidase 2(HAO2)	Homo sapiens						GO:0055114~oxidation-reduction process,GO:0044255~cellular lipid metabolic process,GO:0043436~oxoacid metabolic process,GO:0034440~lipid oxidation,GO:0032787~monocarboxylic acid metabolic process,GO:0030258~lipid modification,GO:0019752~carboxylic acid metabolic process,GO:0019395~fatty acid oxidation,GO:0006631~fatty acid metabolic process,GO:0006629~lipid metabolic process,GO:0006082~organic acid metabolic process,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044439~peroxisomal part,GO:0044438~microbody part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0042579~microbody,GO:0031988~membrane-bounded vesicle,GO:0031907~microbody lumen,GO:0005782~peroxisomal matrix,GO:0005777~peroxisome,GO:0005739~mitochondrion,GO:0005576~extracellular region,															GO:1901363~heterocyclic compound binding,GO:1901265~nucleoside phosphate binding,GO:0097367~carbohydrate derivative binding,GO:0097159~organic cyclic compound binding,GO:0052854~medium-chain-(S)-2-hydroxy-acid oxidase activity,GO:0052853~long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,GO:0052852~very-long-chain-(S)-2-hydroxy-acid oxidase activity,GO:0048037~cofactor binding,GO:0036094~small molecule binding,GO:0032553~ribonucleotide binding,GO:0016899~oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,GO:0016614~oxidoreductase activity, acting on CH-OH group of donors,GO:0010181~FMN binding,GO:0005102~receptor binding,GO:0003973~(S)-2-hydroxy-acid oxidase activity,GO:0000166~nucleotide binding,						IPR013785:Aldolase-type TIM barrel,IPR012133:Alpha-hydroxy acid dehydrogenase, FMN-dependent,IPR008259:FMN-dependent alpha-hydroxy acid dehydrogenase, active site,IPR000262:FMN-dependent dehydrogenase,																			hsa04146:Peroxisome,hsa01200:Carbon metabolism,hsa01130:Biosynthesis of antibiotics,hsa01100:Metabolic pathways,hsa00630:Glyoxylate and dicarboxylate metabolism,				PIRSF000138:alpha-hydroxy acid dehydrogenase, FMN-dependent,														short sequence motif:Microbody targeting signal,sequence variant,sequence conflict,nucleotide phosphate-binding region:FMN,domain:FMN hydroxy acid dehydrogenase,chain:Hydroxyacid oxidase 2,binding site:Substrate,binding site:FMN,active site:Proton acceptor,									
3561	interleukin 2 receptor subunit gamma(IL2RG)	Homo sapiens										h_il7Pathway:IL-7 Signal Transduction,h_il4Pathway:IL 4 signaling pathway,h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation,h_il2Pathway:IL 2 signaling pathway,								GO:0098761~cellular response to interleukin-7,GO:0098760~response to interleukin-7,GO:0071353~cellular response to interleukin-4,GO:0071352~cellular response to interleukin-2,GO:0071345~cellular response to cytokine stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0070670~response to interleukin-4,GO:0070669~response to interleukin-2,GO:0065009~regulation of molecular function,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0050790~regulation of catalytic activity,GO:0044764~multi-organism cellular process,GO:0044419~interspecies interaction between organisms,GO:0044403~symbiosis, encompassing mutualism through parasitism,GO:0044093~positive regulation of molecular function,GO:0043547~positive regulation of GTPase activity,GO:0043087~regulation of GTPase activity,GO:0043085~positive regulation of catalytic activity,GO:0038111~interleukin-7-mediated signaling pathway,GO:0038110~interleukin-2-mediated signaling pathway,GO:0036211~protein modification process,GO:0035771~interleukin-4-mediated signaling pathway,GO:0035556~intracellular signal transduction,GO:0034097~response to cytokine,GO:0023014~signal transduction by protein phosphorylation,GO:0019221~cytokine-mediated signaling pathway,GO:0016310~phosphorylation,GO:0016032~viral process,GO:0010033~response to organic substance,GO:0007166~cell surface receptor signaling pathway,GO:0006955~immune response,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006468~protein phosphorylation,GO:0006464~cellular protein modification process,GO:0000165~MAPK cascade,											GO:0098552~side of membrane,GO:0031226~intrinsic component of plasma membrane,GO:0009986~cell surface,GO:0009897~external side of plasma membrane,GO:0005887~integral component of plasma membrane,															GO:0099600~transmembrane receptor activity,GO:0098772~molecular function regulator,GO:0060089~molecular transducer activity,GO:0038023~signaling receptor activity,GO:0019976~interleukin-2 binding,GO:0019955~cytokine binding,GO:0019838~growth factor binding,GO:0005088~Ras guanyl-nucleotide exchange factor activity,GO:0005085~guanyl-nucleotide exchange factor activity,GO:0004917~interleukin-7 receptor activity,GO:0004913~interleukin-4 receptor activity,GO:0004911~interleukin-2 receptor activity,GO:0004896~cytokine receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,						IPR015321:Interleukin-6 receptor alpha chain, binding,IPR013783:Immunoglobulin-like fold,IPR003961:Fibronectin, type III,IPR003531:Short hematopoietin receptor, family 1, conserved site,																			hsa05340:Primary immunodeficiency,hsa05321:Inflammatory bowel disease (IBD),hsa05166:HTLV-I infection,hsa05162:Measles,hsa04630:Jak-STAT signaling pathway,hsa04151:PI3K-Akt signaling pathway,hsa04144:Endocytosis,hsa04060:Cytokine-cytokine receptor interaction,							312863~Combined immunodeficiency, X-linked, moderate,300400~Severe combined immunodeficiency, X-linked,											turn,transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,strand,signal peptide,short sequence motif:WSXWS motif,short sequence motif:Box 1 motif,sequence variant,modified residue,helix,glycosylation site:N-linked (GlcNAc...),domain:Fibronectin type-III,disulfide bond,chain:Cytokine receptor common subunit gamma,									
353288	keratin 26(KRT26)	Homo sapiens					GO:1903561~extracellular vesicle,GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0070062~extracellular exosome,GO:0045111~intermediate filament cytoskeleton,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0005882~intermediate filament,GO:0005576~extracellular region,															GO:0005198~structural molecule activity,						IPR002957:Keratin, type I,IPR001664:Intermediate filament protein,																					SM01391:SM01391,				sequence variant,sequence conflict,region of interest:Tail,region of interest:Rod,region of interest:Linker 12,region of interest:Linker 1,region of interest:Head,region of interest:Coil 2,region of interest:Coil 1B,region of interest:Coil 1A,compositionally biased region:Gly-rich,chain:Keratin, type I cytoskeletal 26,									
8689	keratin 36(KRT36)	Homo sapiens						GO:2000026~regulation of multicellular organismal development,GO:0060429~epithelium development,GO:0045682~regulation of epidermis development,GO:0045616~regulation of keratinocyte differentiation,GO:0045604~regulation of epidermal cell differentiation,GO:0045595~regulation of cell differentiation,GO:0030856~regulation of epithelial cell differentiation,GO:0030855~epithelial cell differentiation,GO:0009913~epidermal cell differentiation,GO:0008544~epidermis development,											GO:1903561~extracellular vesicle,GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0070062~extracellular exosome,GO:0045111~intermediate filament cytoskeleton,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0005882~intermediate filament,GO:0005576~extracellular region,															GO:0030280~structural constituent of epidermis,GO:0005198~structural molecule activity,						IPR018039:Intermediate filament protein, conserved site,IPR009053:Prefoldin,IPR002957:Keratin, type I,IPR001664:Intermediate filament protein,																					SM01391:SM01391,				splice variant,site:Stutter,sequence variant,region of interest:Tail,region of interest:Rod,region of interest:Linker 12,region of interest:Linker 1,region of interest:Head,region of interest:Coil 2,region of interest:Coil 1B,region of interest:Coil 1A,modified residue,chain:Keratin, type I cuticular Ha6,									
81850	keratin associated protein 1-3(KRTAP1-3)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,															GO:0030280~structural constituent of epidermis,GO:0005198~structural molecule activity,						IPR002494:High sulphur keratin-associated protein,													sequence variant,sequence conflict,chain:Keratin-associated protein 1-4,chain:Keratin-associated protein 1-3,									
337959	keratin associated protein 13-2(KRTAP13-2)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0005882~intermediate filament,									IPR007951:PMG,													sequence variant,repeat:5,repeat:4,repeat:3,repeat:2,repeat:1,region of interest:5 X 10 AA approximate repeats,chain:Keratin-associated protein 13-2,									
100505753	keratin associated protein 16-1(KRTAP16-1)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,										
337882	keratin associated protein 19-1(KRTAP19-1)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0005882~intermediate filament,									IPR021743:Keratin-associated matrix,													region of interest:26 X 2 AA repeats of G-[YCGS],chain:Keratin-associated protein 19-1,									
337972	keratin associated protein 19-5(KRTAP19-5)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0005882~intermediate filament,									IPR021743:Keratin-associated matrix,													chain:Keratin-associated protein 19-5,									
728279	keratin associated protein 2-2(KRTAP2-2)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													region of interest:10 X 5 AA repeats of C-C-[CDPQRWG]- [APRS]-[CIPSTVD],region of interest:10 X 5 AA repeats of C-C-[CDPQRW]- [ADPRS]-[CIPSTV],chain:Keratin-associated protein 2-4,chain:Keratin-associated protein 2-3,chain:Keratin-associated protein 2-1,									
85294	keratin associated protein 2-4(KRTAP2-4)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													region of interest:10 X 5 AA repeats of C-C-[CDPQRWG]- [APRS]-[CIPSTVD],region of interest:10 X 5 AA repeats of C-C-[CDPQRW]- [ADPRS]-[CIPSTV],chain:Keratin-associated protein 2-4,chain:Keratin-associated protein 2-3,chain:Keratin-associated protein 2-1,									
643803	keratin associated protein 24-1(KRTAP24-1)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,															GO:0005198~structural molecule activity,						IPR007951:PMG,IPR007659:Keratin, high-sulphur matrix protein,													repeat:6,repeat:5,repeat:4,repeat:3,repeat:2,repeat:1,region of interest:6 X 10 AA repeats of Y-[ILR]-[SVPC]- [NRTS]-[SNTG]-X-[QHRP]-[PSY]-[QSL]-[SRK],chain:Keratin-associated protein 24-1,									
388818	keratin associated protein 26-1(KRTAP26-1)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0005882~intermediate filament,									IPR007951:PMG,													sequence variant,chain:Keratin-associated protein 26-1,									
83897	keratin associated protein 3-2(KRTAP3-2)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,															GO:0005198~structural molecule activity,						IPR007659:Keratin, high-sulphur matrix protein,													sequence variant,repeat:3,repeat:2,repeat:1,region of interest:3 X 5 AA repeats of C-C-X(3),chain:Keratin-associated protein 3-2,									
85285	keratin associated protein 4-1(KRTAP4-1)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:2,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:16 X 5 AA repeats of C-C-[GRQC]-[SPT]- [VSTL],chain:Keratin-associated protein 4-1,									
653240	keratin associated protein 4-11(KRTAP4-11)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:29,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:29 X 5 AA repeats of C-C-[IRQVEL]-[SPTR]- [STVQRCP],region of interest:27 X 5 AA repeats of C-C-[GIKRQVHEL]- [SPTR]-[STVQRMC],region of interest:25 X 5 AA repeats of C-C-[IKRQVHEC]- [SPRT]-[STCVQPR],region of interest:20 X 5 AA repeats of C-C-[GIKRQVHEML]- [SPTRV]-[STVQRCP],chain:Putative keratin-associated protein 4-X,chain:Keratin-associated protein 4-8,chain:Keratin-associated protein 4-6,chain:Keratin-associated protein 4-11,									
83755	keratin associated protein 4-12(KRTAP4-12)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:30,repeat:3,repeat:29,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:31 X 5 AA repeats of C-C-[GRQVIL]-[SPTR]- [VSTQPC],chain:Keratin-associated protein 4-12,									
85291	keratin associated protein 4-2(KRTAP4-2)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:20 X 5 AA repeats OF C-C-[GRQVS]-[SPT]- [VSTQ],chain:Keratin-associated protein 4-2,									
85290	keratin associated protein 4-3(KRTAP4-3)	Homo sapiens						GO:0042633~hair cycle,GO:0042303~molting cycle,GO:0007568~aging,											GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:29 X 5 AA repeats of C-C-[GIKRQVH]-[SPT]- [STA],chain:Keratin-associated protein 4-3,									
85289	keratin associated protein 4-5(KRTAP4-5)	Homo sapiens						GO:0042633~hair cycle,GO:0042303~molting cycle,GO:0007568~aging,											GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:26 X 5 AA repeats of C-C-[GRQVCHIEK]- [SPTR]-[VSTQYC],chain:Keratin-associated protein 4-5,									
81871	keratin associated protein 4-6(KRTAP4-6)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:29,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:29 X 5 AA repeats of C-C-[IRQVEL]-[SPTR]- [STVQRCP],region of interest:27 X 5 AA repeats of C-C-[GIKRQVHEL]- [SPTR]-[STVQRMC],region of interest:25 X 5 AA repeats of C-C-[IKRQVHEC]- [SPRT]-[STCVQPR],region of interest:20 X 5 AA repeats of C-C-[GIKRQVHEML]- [SPTRV]-[STVQRCP],chain:Putative keratin-associated protein 4-X,chain:Keratin-associated protein 4-8,chain:Keratin-associated protein 4-6,chain:Keratin-associated protein 4-11,									
100132476	keratin associated protein 4-7(KRTAP4-7)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:29,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:29 X 5 AA repeats of C-C-[IRQVEL]-[SPTR]- [STVQRCP],region of interest:27 X 5 AA repeats of C-C-[GIKRQVHEL]- [SPTR]-[STVQRMC],region of interest:25 X 5 AA repeats of C-C-[IKRQVHEC]- [SPRT]-[STCVQPR],region of interest:20 X 5 AA repeats of C-C-[GIKRQVHEML]- [SPTRV]-[STVQRCP],chain:Putative keratin-associated protein 4-X,chain:Keratin-associated protein 4-8,chain:Keratin-associated protein 4-6,chain:Keratin-associated protein 4-11,									
728224	keratin associated protein 4-8(KRTAP4-8)	Homo sapiens						GO:0042633~hair cycle,GO:0042303~molting cycle,GO:0007568~aging,											GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:29,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:29 X 5 AA repeats of C-C-[IRQVEL]-[SPTR]- [STVQRCP],region of interest:27 X 5 AA repeats of C-C-[GIKRQVHEL]- [SPTR]-[STVQRMC],region of interest:25 X 5 AA repeats of C-C-[IKRQVHEC]- [SPRT]-[STCVQPR],region of interest:20 X 5 AA repeats of C-C-[GIKRQVHEML]- [SPTRV]-[STVQRCP],chain:Putative keratin-associated protein 4-X,chain:Keratin-associated protein 4-8,chain:Keratin-associated protein 4-6,chain:Keratin-associated protein 4-11,									
100132386	keratin associated protein 4-9(KRTAP4-9)	Homo sapiens						GO:0042633~hair cycle,GO:0042303~molting cycle,GO:0007568~aging,											GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:29,repeat:28,repeat:27,repeat:26,repeat:25,repeat:24,repeat:23,repeat:22,repeat:21,repeat:20,repeat:2,repeat:19,repeat:18,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:10,repeat:1,region of interest:29 X 5 AA repeats of C-C-[RQVHIEK]- [SPTR]-[VSTQCRNP],chain:Keratin-associated protein 4-9,									
83899	keratin associated protein 9-2(KRTAP9-2)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,															GO:0042802~identical protein binding,						IPR002494:High sulphur keratin-associated protein,													splice variant,sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:2,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:17 X 5 AA repeats of C-C-[RQVSGE]-[SPTQ]- [TASP],region of interest:14 X 5 AA repeats of C-C-[RQVGE]- [SPSTNQ]-[TASL],chain:Keratin-associated protein 9-9,chain:Keratin-associated protein 9-2,									
83900	keratin associated protein 9-3(KRTAP9-3)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:2,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:16 X 5 AA repeats of C-C-[RQVSHE]-[SPTN]- [TASPI],chain:Keratin-associated protein 9-3,									
85280	keratin associated protein 9-4(KRTAP9-4)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:2,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:15 X 5 AA repeats of C-C-[RQVGE]-[SPTN]- [TASPF],chain:Keratin-associated protein 9-4,									
81870	keratin associated protein 9-9(KRTAP9-9)	Homo sapiens					GO:0099513~polymeric cytoskeletal fiber,GO:0099512~supramolecular fiber,GO:0045111~intermediate filament cytoskeleton,GO:0045095~keratin filament,GO:0005882~intermediate filament,									IPR002494:High sulphur keratin-associated protein,													splice variant,sequence variant,repeat:9,repeat:8,repeat:7,repeat:6,repeat:5,repeat:4,repeat:3,repeat:2,repeat:17,repeat:16,repeat:15,repeat:14,repeat:13,repeat:12,repeat:11,repeat:10,repeat:1,region of interest:17 X 5 AA repeats of C-C-[RQVSGE]-[SPTQ]- [TASP],region of interest:14 X 5 AA repeats of C-C-[RQVGE]- [SPSTNQ]-[TASL],chain:Keratin-associated protein 9-9,chain:Keratin-associated protein 9-2,									
3820	killer cell lectin like receptor B1(KLRB1)	Homo sapiens						GO:0050776~regulation of immune response,GO:0007166~cell surface receptor signaling pathway,GO:0002682~regulation of immune system process,														GO:0099600~transmembrane receptor activity,GO:0060089~molecular transducer activity,GO:0038023~signaling receptor activity,GO:0030246~carbohydrate binding,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,						IPR016187:C-type lectin fold,IPR016186:C-type lectin-like,IPR001304:C-type lectin,																			hsa05144:Malaria,														SM00034:CLECT,				transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,sequence variant,glycosylation site:N-linked (GlcNAc...),domain:C-type lectin,disulfide bond,chain:Killer cell lectin-like receptor subfamily B member 1,									
353144	late cornified envelope 3C(LCE3C)	Homo sapiens						GO:0060429~epithelium development,GO:0043588~skin development,GO:0036211~protein modification process,GO:0031424~keratinization,GO:0030855~epithelial cell differentiation,GO:0030216~keratinocyte differentiation,GO:0018149~peptide cross-linking,GO:0009913~epidermal cell differentiation,GO:0008544~epidermis development,GO:0006464~cellular protein modification process,											GO:0001533~cornified envelope,															GO:0005198~structural molecule activity,						IPR026075:Small proline-rich protein/late cornified envelope protein,													compositionally biased region:Pro-rich,chain:Late cornified envelope protein 3C,									
7940	leukocyte specific transcript 1(LST1)	Homo sapiens						GO:0070664~negative regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051128~regulation of cellular component organization,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048699~generation of neurons,GO:0048666~neuron development,GO:0048468~cell development,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0045321~leukocyte activation,GO:0042127~regulation of cell proliferation,GO:0032989~cellular component morphogenesis,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0031175~neuron projection development,GO:0030182~neuron differentiation,GO:0030030~cell projection organization,GO:0022604~regulation of cell morphogenesis,GO:0022603~regulation of anatomical structure morphogenesis,GO:0022008~neurogenesis,GO:0016358~dendrite development,GO:0008360~regulation of cell shape,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007399~nervous system development,GO:0006955~immune response,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0001775~cell activation,GO:0000902~cell morphogenesis,											GO:0044431~Golgi apparatus part,GO:0005794~Golgi apparatus,GO:0000139~Golgi membrane,									IPR007775:Leukocyte-specific transcript 1, LST-1,											PIRSF037638:leukocyte-specific transcript 1 protein ,														transmembrane region,splice variant,sequence conflict,modified residue,chain:Leukocyte-specific transcript 1 protein,									
2315	melan-A(MLANA)	Homo sapiens					GO:0098791~Golgi subcompartment,GO:0048770~pigment granule,GO:0044432~endoplasmic reticulum part,GO:0044431~Golgi apparatus part,GO:0042470~melanosome,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0031988~membrane-bounded vesicle,GO:0031984~organelle subcompartment,GO:0031226~intrinsic component of plasma membrane,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0005887~integral component of plasma membrane,GO:0005802~trans-Golgi network,GO:0005794~Golgi apparatus,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,										transmembrane region,topological domain:Cytoplasmic,chain:Melanoma antigen recognized by T-cells 1,									
4161	melanocortin 5 receptor(MC5R)	Homo sapiens						GO:1901566~organonitrogen compound biosynthetic process,GO:1901293~nucleoside phosphate biosynthetic process,GO:1901137~carbohydrate derivative biosynthetic process,GO:1901135~carbohydrate derivative metabolic process,GO:1900544~positive regulation of purine nucleotide metabolic process,GO:1900542~regulation of purine nucleotide metabolic process,GO:1900373~positive regulation of purine nucleotide biosynthetic process,GO:1900371~regulation of purine nucleotide biosynthetic process,GO:0090407~organophosphate biosynthetic process,GO:0072522~purine-containing compound biosynthetic process,GO:0072521~purine-containing compound metabolic process,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0052652~cyclic purine nucleotide metabolic process,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0046390~ribose phosphate biosynthetic process,GO:0046058~cAMP metabolic process,GO:0045981~positive regulation of nucleotide metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0030816~positive regulation of cAMP metabolic process,GO:0030814~regulation of cAMP metabolic process,GO:0030810~positive regulation of nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030804~positive regulation of cyclic nucleotide biosynthetic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030801~positive regulation of cyclic nucleotide metabolic process,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0019693~ribose phosphate metabolic process,GO:0019637~organophosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009260~ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009190~cyclic nucleotide biosynthetic process,GO:0009187~cyclic nucleotide metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009117~nucleotide metabolic process,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor signaling pathway,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006171~cAMP biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006163~purine nucleotide metabolic process,GO:0006140~regulation of nucleotide metabolic process,											GO:0031226~intrinsic component of plasma membrane,GO:0005887~integral component of plasma membrane,															GO:0099600~transmembrane receptor activity,GO:0060089~molecular transducer activity,GO:0042562~hormone binding,GO:0038023~signaling receptor activity,GO:0008528~G-protein coupled peptide receptor activity,GO:0004977~melanocortin receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0001653~peptide receptor activity,						IPR017452:GPCR, rhodopsin-like, 7TM,IPR001908:Melanocortin receptor,IPR001671:Melanocortin/ACTH receptor,IPR000621:Melanocortin 5 receptor,IPR000276:G protein-coupled receptor, rhodopsin-like,																			hsa04080:Neuroactive ligand-receptor interaction,														SM01381:SM01381,				transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,sequence variant,sequence conflict,mutagenesis site,lipid moiety-binding region:S-palmitoyl cysteine,glycosylation site:N-linked (GlcNAc...),chain:Melanocortin receptor 5,									
4496	metallothionein 1H(MT1H)	Homo sapiens						GO:1990267~response to transition metal nanoparticle,GO:0071294~cellular response to zinc ion,GO:0071276~cellular response to cadmium ion,GO:0071248~cellular response to metal ion,GO:0071241~cellular response to inorganic substance,GO:0070887~cellular response to chemical stimulus,GO:0046686~response to cadmium ion,GO:0045926~negative regulation of growth,GO:0040008~regulation of growth,GO:0040007~growth,GO:0010043~response to zinc ion,GO:0010038~response to metal ion,GO:0010035~response to inorganic substance,											GO:0048471~perinuclear region of cytoplasm,															GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0008270~zinc ion binding,						IPR023587:Metallothionein domain, vertebrate,IPR018064:Metallothionein, vertebrate, metal binding site,IPR017854:Metallothionein domain,IPR003019:Metallothionein superfamily, eukaryotic,IPR000006:Metallothionein, vertebrate,																			hsa04978:Mineral absorption,						region of interest:Beta,region of interest:Alpha,modified residue,metal ion-binding site:Divalent metal cation; cluster B,metal ion-binding site:Divalent metal cation; cluster A,chain:Metallothionein-1H,									
84560	metallothionein 4(MT4)	Homo sapiens						GO:0098771~inorganic ion homeostasis,GO:0055082~cellular chemical homeostasis,GO:0055080~cation homeostasis,GO:0055065~metal ion homeostasis,GO:0050801~ion homeostasis,GO:0048878~chemical homeostasis,GO:0042592~homeostatic process,GO:0030003~cellular cation homeostasis,GO:0019725~cellular homeostasis,GO:0006875~cellular metal ion homeostasis,GO:0006873~cellular ion homeostasis,														GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,						IPR023587:Metallothionein domain, vertebrate,IPR017854:Metallothionein domain,IPR003019:Metallothionein superfamily, eukaryotic,IPR000006:Metallothionein, vertebrate,													sequence variant,metal ion-binding site:Divalent metal cation; cluster B,metal ion-binding site:Divalent metal cation; cluster A,chain:Metallothionein-4,									
4332	myeloid cell nuclear differentiation antigen(MNDA)	Homo sapiens						GO:2001141~regulation of RNA biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903506~regulation of nucleic acid-templated transcription,GO:0097659~nucleic acid-templated transcription,GO:0070664~negative regulation of leukocyte proliferation,GO:0070663~regulation of leukocyte proliferation,GO:0070661~leukocyte proliferation,GO:0051252~regulation of RNA metabolic process,GO:0051250~negative regulation of lymphocyte activation,GO:0051249~regulation of lymphocyte activation,GO:0051171~regulation of nitrogen compound metabolic process,GO:0050869~negative regulation of B cell activation,GO:0050866~negative regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050864~regulation of B cell activation,GO:0050853~B cell receptor signaling pathway,GO:0050851~antigen receptor-mediated signaling pathway,GO:0050778~positive regulation of immune response,GO:0050776~regulation of immune response,GO:0050672~negative regulation of lymphocyte proliferation,GO:0050670~regulation of lymphocyte proliferation,GO:0048584~positive regulation of response to stimulus,GO:0046651~lymphocyte proliferation,GO:0046649~lymphocyte activation,GO:0045321~leukocyte activation,GO:0043068~positive regulation of programmed cell death,GO:0043067~regulation of programmed cell death,GO:0043065~positive regulation of apoptotic process,GO:0042981~regulation of apoptotic process,GO:0042127~regulation of cell proliferation,GO:0042113~B cell activation,GO:0042100~B cell proliferation,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0033554~cellular response to stress,GO:0032945~negative regulation of mononuclear cell proliferation,GO:0032944~regulation of mononuclear cell proliferation,GO:0032943~mononuclear cell proliferation,GO:0032774~RNA biosynthetic process,GO:0030889~negative regulation of B cell proliferation,GO:0030888~regulation of B cell proliferation,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0012501~programmed cell death,GO:0010942~positive regulation of cell death,GO:0010941~regulation of cell death,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0008219~cell death,GO:0007166~cell surface receptor signaling pathway,GO:0006974~cellular response to DNA damage stimulus,GO:0006968~cellular defense response,GO:0006955~immune response,GO:0006952~defense response,GO:0006915~apoptotic process,GO:0006355~regulation of transcription, DNA-templated,GO:0006351~transcription, DNA-templated,GO:0002768~immune response-regulating cell surface receptor signaling pathway,GO:0002764~immune response-regulating signaling pathway,GO:0002757~immune response-activating signal transduction,GO:0002695~negative regulation of leukocyte activation,GO:0002694~regulation of leukocyte activation,GO:0002684~positive regulation of immune system process,GO:0002683~negative regulation of immune system process,GO:0002682~regulation of immune system process,GO:0002429~immune response-activating cell surface receptor signaling pathway,GO:0002253~activation of immune response,GO:0001775~cell activation,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044451~nucleoplasm part,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0034399~nuclear periphery,GO:0031988~membrane-bounded vesicle,GO:0016607~nuclear speck,GO:0016604~nuclear body,GO:0005654~nucleoplasm,GO:0005576~extracellular region,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,						IPR004021:HIN-200/IF120x,IPR004020:DAPIN domain,																					SM01289:SM01289,				turn,short sequence motif:Nuclear localization signal,sequence variant,helix,domain:HIN-200,domain:DAPIN,chain:Myeloid cell nuclear differentiation antigen,									
4759	neuraminidase 2(NEU2)	Homo sapiens						GO:1903509~liposaccharide metabolic process,GO:1901565~organonitrogen compound catabolic process,GO:1901136~carbohydrate derivative catabolic process,GO:1901135~carbohydrate derivative metabolic process,GO:0046514~ceramide catabolic process,GO:0046479~glycosphingolipid catabolic process,GO:0046466~membrane lipid catabolic process,GO:0044724~single-organism carbohydrate catabolic process,GO:0044723~single-organism carbohydrate metabolic process,GO:0044712~single-organism catabolic process,GO:0044255~cellular lipid metabolic process,GO:0044248~cellular catabolic process,GO:0044242~cellular lipid catabolic process,GO:0043603~cellular amide metabolic process,GO:0030149~sphingolipid catabolic process,GO:0019377~glycolipid catabolic process,GO:0016052~carbohydrate catabolic process,GO:0016042~lipid catabolic process,GO:0009313~oligosaccharide catabolic process,GO:0009311~oligosaccharide metabolic process,GO:0006689~ganglioside catabolic process,GO:0006687~glycosphingolipid metabolic process,GO:0006672~ceramide metabolic process,GO:0006665~sphingolipid metabolic process,GO:0006664~glycolipid metabolic process,GO:0006643~membrane lipid metabolic process,GO:0006629~lipid metabolic process,GO:0005975~carbohydrate metabolic process,GO:0001573~ganglioside metabolic process,											GO:0005829~cytosol,															GO:0052796~exo-alpha-(2->8)-sialidase activity,GO:0052795~exo-alpha-(2->6)-sialidase activity,GO:0052794~exo-alpha-(2->3)-sialidase activity,GO:0016997~alpha-sialidase activity,GO:0016798~hydrolase activity, acting on glycosyl bonds,GO:0004553~hydrolase activity, hydrolyzing O-glycosyl compounds,GO:0004308~exo-alpha-sialidase activity,						IPR026945:Sialidase-2,IPR026856:Sialidase family,IPR011040:Sialidases,																			hsa00600:Sphingolipid metabolism,hsa00511:Other glycan degradation,						turn,strand,short sequence motif:FRIP motif,sequence variant,repeat:BNR 2,repeat:BNR 1,helix,chain:Sialidase-2,binding site:Substrate,active site:Proton acceptor,active site:Nucleophile,									
2831	neuropeptides B/W receptor 1(NPBWR1)	Homo sapiens						GO:0099537~trans-synaptic signaling,GO:0099536~synaptic signaling,GO:0098916~anterograde trans-synaptic signaling,GO:0038003~opioid receptor signaling pathway,GO:0007268~chemical synaptic transmission,GO:0007267~cell-cell signaling,GO:0007218~neuropeptide signaling pathway,GO:0007187~G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,GO:0007186~G-protein coupled receptor signaling pathway,											GO:0097458~neuron part,GO:0043005~neuron projection,GO:0031226~intrinsic component of plasma membrane,GO:0005887~integral component of plasma membrane,															GO:0099600~transmembrane receptor activity,GO:0060089~molecular transducer activity,GO:0042923~neuropeptide binding,GO:0042277~peptide binding,GO:0038023~signaling receptor activity,GO:0033218~amide binding,GO:0008528~G-protein coupled peptide receptor activity,GO:0008188~neuropeptide receptor activity,GO:0004985~opioid receptor activity,GO:0004930~G-protein coupled receptor activity,GO:0004888~transmembrane signaling receptor activity,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0001653~peptide receptor activity,						IPR027348:Neuropeptide B/W receptor 1,IPR017452:GPCR, rhodopsin-like, 7TM,IPR009150:Neuropeptide B/W receptor family,IPR000276:G protein-coupled receptor, rhodopsin-like,																			hsa04080:Neuroactive ligand-receptor interaction,						transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,sequence variant,sequence conflict,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Neuropeptides B/W receptor type 1,									
9970	nuclear receptor subfamily 1 group I member 3(NR1I3)	Homo sapiens										h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity,h_acetaminophenPathway:Mechanism of Acetaminophen Activity and Toxicity,								GO:2001141~regulation of RNA biosynthetic process,GO:2000113~negative regulation of cellular macromolecule biosynthetic process,GO:2000112~regulation of cellular macromolecule biosynthetic process,GO:1903508~positive regulation of nucleic acid-templated transcription,GO:1903507~negative regulation of nucleic acid-templated transcription,GO:1903506~regulation of nucleic acid-templated transcription,GO:1902680~positive regulation of RNA biosynthetic process,GO:1902679~negative regulation of RNA biosynthetic process,GO:0097659~nucleic acid-templated transcription,GO:0071495~cellular response to endogenous stimulus,GO:0071407~cellular response to organic cyclic compound,GO:0071396~cellular response to lipid,GO:0071383~cellular response to steroid hormone stimulus,GO:0071310~cellular response to organic substance,GO:0070887~cellular response to chemical stimulus,GO:0051254~positive regulation of RNA metabolic process,GO:0051253~negative regulation of RNA metabolic process,GO:0051252~regulation of RNA metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051172~negative regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0048545~response to steroid hormone,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0045934~negative regulation of nucleobase-containing compound metabolic process,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045892~negative regulation of transcription, DNA-templated,GO:0043401~steroid hormone mediated signaling pathway,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0033993~response to lipid,GO:0032870~cellular response to hormone stimulus,GO:0032774~RNA biosynthetic process,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030522~intracellular receptor signaling pathway,GO:0030521~androgen receptor signaling pathway,GO:0030518~intracellular steroid hormone receptor signaling pathway,GO:0019438~aromatic compound biosynthetic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0016070~RNA metabolic process,GO:0014070~response to organic cyclic compound,GO:0010629~negative regulation of gene expression,GO:0010628~positive regulation of gene expression,GO:0010605~negative regulation of macromolecule metabolic process,GO:0010604~positive regulation of macromolecule metabolic process,GO:0010558~negative regulation of macromolecule biosynthetic process,GO:0010557~positive regulation of macromolecule biosynthetic process,GO:0010556~regulation of macromolecule biosynthetic process,GO:0010468~regulation of gene expression,GO:0010467~gene expression,GO:0010033~response to organic substance,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009890~negative regulation of biosynthetic process,GO:0009755~hormone-mediated signaling pathway,GO:0009725~response to hormone,GO:0009719~response to endogenous stimulus,GO:0006367~transcription initiation from RNA polymerase II promoter,GO:0006366~transcription from RNA polymerase II promoter,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006355~regulation of transcription, DNA-templated,GO:0006352~DNA-templated transcription, initiation,GO:0006351~transcription, DNA-templated,											GO:0005829~cytosol,GO:0005654~nucleoplasm,															GO:1990837~sequence-specific double-stranded DNA binding,GO:1901363~heterocyclic compound binding,GO:0098531~transcription factor activity, direct ligand regulated sequence-specific DNA binding,GO:0097159~organic cyclic compound binding,GO:0060089~molecular transducer activity,GO:0046914~transition metal ion binding,GO:0046872~metal ion binding,GO:0044212~transcription regulatory region DNA binding,GO:0043565~sequence-specific DNA binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0038023~signaling receptor activity,GO:0008270~zinc ion binding,GO:0004887~thyroid hormone receptor activity,GO:0004882~androgen receptor activity,GO:0004879~RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,GO:0004872~receptor activity,GO:0004871~signal transducer activity,GO:0003713~transcription coactivator activity,GO:0003712~transcription cofactor activity,GO:0003707~steroid hormone receptor activity,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003690~double-stranded DNA binding,GO:0003677~DNA binding,GO:0003676~nucleic acid binding,GO:0001228~transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,GO:0001071~nucleic acid binding transcription factor activity,GO:0001067~regulatory region nucleic acid binding,GO:0001012~RNA polymerase II regulatory region DNA binding,GO:0000989~transcription factor activity, transcription factor binding,GO:0000988~transcription factor activity, protein binding,GO:0000981~RNA polymerase II transcription factor activity, sequence-specific DNA binding,GO:0000977~RNA polymerase II regulatory region sequence-specific DNA binding,GO:0000976~transcription regulatory region sequence-specific DNA binding,GO:0000975~regulatory region DNA binding,						IPR013088:Zinc finger, NHR/GATA-type,IPR001728:Thyroid hormone receptor,IPR001723:Steroid hormone receptor,IPR001628:Zinc finger, nuclear hormone receptor-type,IPR000536:Nuclear hormone receptor, ligand-binding, core,																					SM00430:HOLI,SM00399:ZnF_C4,				zinc finger region:NR C4-type,turn,strand,splice variant,sequence variant,helix,DNA-binding region:Nuclear receptor,chain:Nuclear receptor subfamily 1 group I member 3,									
5341	pleckstrin(PLEK)	Homo sapiens						GO:1903036~positive regulation of response to wounding,GO:1903034~regulation of response to wounding,GO:1902931~negative regulation of alcohol biosynthetic process,GO:1902930~regulation of alcohol biosynthetic process,GO:1902589~single-organism organelle organization,GO:1902532~negative regulation of intracellular signal transduction,GO:1902531~regulation of intracellular signal transduction,GO:1901881~positive regulation of protein depolymerization,GO:1901879~regulation of protein depolymerization,GO:1901617~organic hydroxy compound biosynthetic process,GO:1901615~organic hydroxy compound metabolic process,GO:1900048~positive regulation of hemostasis,GO:1900046~regulation of hemostasis,GO:0098609~cell-cell adhesion,GO:0098602~single organism cell adhesion,GO:0090407~organophosphate biosynthetic process,GO:0090303~positive regulation of wound healing,GO:0090066~regulation of anatomical structure size,GO:0080134~regulation of response to stress,GO:0071822~protein complex subunit organization,GO:0070560~protein secretion by platelet,GO:0070528~protein kinase C signaling,GO:0070527~platelet aggregation,GO:0070493~thrombin receptor signaling pathway,GO:0070271~protein complex biogenesis,GO:0065009~regulation of molecular function,GO:0065003~macromolecular complex assembly,GO:0061572~actin filament bundle organization,GO:0061041~regulation of wound healing,GO:0060305~regulation of cell diameter,GO:0051495~positive regulation of cytoskeleton organization,GO:0051493~regulation of cytoskeleton organization,GO:0051345~positive regulation of hydrolase activity,GO:0051336~regulation of hydrolase activity,GO:0051261~protein depolymerization,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051130~positive regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051017~actin filament bundle assembly,GO:0050878~regulation of body fluid levels,GO:0050867~positive regulation of cell activation,GO:0050865~regulation of cell activation,GO:0050849~negative regulation of calcium-mediated signaling,GO:0050848~regulation of calcium-mediated signaling,GO:0050820~positive regulation of coagulation,GO:0050818~regulation of coagulation,GO:0050817~coagulation,GO:0050790~regulation of catalytic activity,GO:0048585~negative regulation of response to stimulus,GO:0048584~positive regulation of response to stimulus,GO:0048534~hematopoietic or lymphoid organ development,GO:0048278~vesicle docking,GO:0046903~secretion,GO:0046488~phosphatidylinositol metabolic process,GO:0046486~glycerolipid metabolic process,GO:0046173~polyol biosynthetic process,GO:0046165~alcohol biosynthetic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045936~negative regulation of phosphate metabolic process,GO:0045912~negative regulation of carbohydrate metabolic process,GO:0045744~negative regulation of G-protein coupled receptor protein signaling pathway,GO:0045184~establishment of protein localization,GO:0045055~regulated exocytosis,GO:0044723~single-organism carbohydrate metabolic process,GO:0044283~small molecule biosynthetic process,GO:0044262~cellular carbohydrate metabolic process,GO:0044255~cellular lipid metabolic process,GO:0044093~positive regulation of molecular function,GO:0044089~positive regulation of cellular component biogenesis,GO:0044087~regulation of cellular component biogenesis,GO:0044085~cellular component biogenesis,GO:0043933~macromolecular complex subunit organization,GO:0043647~inositol phosphate metabolic process,GO:0043624~cellular protein complex disassembly,GO:0043255~regulation of carbohydrate biosynthetic process,GO:0043254~regulation of protein complex assembly,GO:0043244~regulation of protein complex disassembly,GO:0043243~positive regulation of protein complex disassembly,GO:0043241~protein complex disassembly,GO:0043085~positive regulation of catalytic activity,GO:0042060~wound healing,GO:0035556~intracellular signal transduction,GO:0035306~positive regulation of dephosphorylation,GO:0035303~regulation of dephosphorylation,GO:0034109~homotypic cell-cell adhesion,GO:0033625~positive regulation of integrin activation,GO:0033623~regulation of integrin activation,GO:0033622~integrin activation,GO:0033043~regulation of organelle organization,GO:0033036~macromolecule localization,GO:0032984~macromolecular complex disassembly,GO:0032970~regulation of actin filament-based process,GO:0032958~inositol phosphate biosynthetic process,GO:0032956~regulation of actin cytoskeleton organization,GO:0032940~secretion by cell,GO:0032535~regulation of cellular component size,GO:0032233~positive regulation of actin filament bundle assembly,GO:0032231~regulation of actin filament bundle assembly,GO:0032101~regulation of response to external stimulus,GO:0031532~actin cytoskeleton reorganization,GO:0031529~ruffle organization,GO:0031334~positive regulation of protein complex assembly,GO:0031327~negative regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0031324~negative regulation of cellular metabolic process,GO:0030866~cortical actin cytoskeleton organization,GO:0030865~cortical cytoskeleton organization,GO:0030845~phospholipase C-inhibiting G-protein coupled receptor signaling pathway,GO:0030836~positive regulation of actin filament depolymerization,GO:0030834~regulation of actin filament depolymerization,GO:0030832~regulation of actin filament length,GO:0030194~positive regulation of blood coagulation,GO:0030193~regulation of blood coagulation,GO:0030168~platelet activation,GO:0030097~hemopoiesis,GO:0030042~actin filament depolymerization,GO:0030036~actin cytoskeleton organization,GO:0030030~cell projection organization,GO:0030029~actin filament-based process,GO:0023057~negative regulation of signaling,GO:0023051~regulation of signaling,GO:0022610~biological adhesion,GO:0022607~cellular component assembly,GO:0022411~cellular component disassembly,GO:0022406~membrane docking,GO:0019932~second-messenger-mediated signaling,GO:0019751~polyol metabolic process,GO:0019722~calcium-mediated signaling,GO:0019637~organophosphate metabolic process,GO:0019220~regulation of phosphate metabolic process,GO:0016337~single organismal cell-cell adhesion,GO:0016311~dephosphorylation,GO:0016192~vesicle-mediated transport,GO:0016051~carbohydrate biosynthetic process,GO:0015031~protein transport,GO:0010925~positive regulation of inositol-polyphosphate 5-phosphatase activity,GO:0010924~regulation of inositol-polyphosphate 5-phosphatase activity,GO:0010922~positive regulation of phosphatase activity,GO:0010921~regulation of phosphatase activity,GO:0010920~negative regulation of inositol phosphate biosynthetic process,GO:0010919~regulation of inositol phosphate biosynthetic process,GO:0010677~negative regulation of cellular carbohydrate metabolic process,GO:0010675~regulation of cellular carbohydrate metabolic process,GO:0010648~negative regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010638~positive regulation of organelle organization,GO:0010572~positive regulation of platelet activation,GO:0010563~negative regulation of phosphorus metabolic process,GO:0010562~positive regulation of phosphorus metabolic process,GO:0010543~regulation of platelet activation,GO:0009968~negative regulation of signal transduction,GO:0009966~regulation of signal transduction,GO:0009893~positive regulation of metabolic process,GO:0009892~negative regulation of metabolic process,GO:0009890~negative regulation of biosynthetic process,GO:0009611~response to wounding,GO:0009605~response to external stimulus,GO:0009306~protein secretion,GO:0008361~regulation of cell size,GO:0008277~regulation of G-protein coupled receptor protein signaling pathway,GO:0008154~actin polymerization or depolymerization,GO:0008104~protein localization,GO:0008064~regulation of actin polymerization or depolymerization,GO:0007599~hemostasis,GO:0007596~blood coagulation,GO:0007229~integrin-mediated signaling pathway,GO:0007186~G-protein coupled receptor signaling pathway,GO:0007166~cell surface receptor signaling pathway,GO:0007155~cell adhesion,GO:0007015~actin filament organization,GO:0007010~cytoskeleton organization,GO:0006904~vesicle docking involved in exocytosis,GO:0006887~exocytosis,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006650~glycerophospholipid metabolic process,GO:0006644~phospholipid metabolic process,GO:0006629~lipid metabolic process,GO:0006461~protein complex assembly,GO:0006109~regulation of carbohydrate metabolic process,GO:0006066~alcohol metabolic process,GO:0005975~carbohydrate metabolic process,GO:0002576~platelet degranulation,GO:0002520~immune system development,GO:0002244~hematopoietic progenitor cell differentiation,GO:0001775~cell activation,											GO:0098590~plasma membrane region,GO:0032587~ruffle membrane,GO:0031256~leading edge membrane,GO:0031253~cell projection membrane,GO:0031252~cell leading edge,GO:0005829~cytosol,GO:0005576~extracellular region,GO:0001726~ruffle,															GO:0046983~protein dimerization activity,GO:0043325~phosphatidylinositol-3,4-bisphosphate binding,GO:0043168~anion binding,GO:0043167~ion binding,GO:0042803~protein homodimerization activity,GO:0042802~identical protein binding,GO:0019901~protein kinase binding,GO:0019900~kinase binding,GO:0019899~enzyme binding,GO:0005080~protein kinase C binding,						IPR011993:Pleckstrin homology-like domain,IPR011991:Winged helix-turn-helix DNA-binding domain,IPR001849:Pleckstrin homology domain,IPR000591:DEP domain,																					SM00233:PH,SM00049:DEP,				turn,strand,sequence variant,sequence conflict,modified residue,helix,domain:PH 2,domain:PH 1,domain:DEP,chain:Pleckstrin,									
79057	proline rich and Gla domain 3(PRRG3)	Homo sapiens					GO:0005576~extracellular region,															GO:0046872~metal ion binding,GO:0043169~cation binding,GO:0043167~ion binding,GO:0005509~calcium ion binding,						IPR017857:Coagulation factor, subgroup, Gla domain,IPR000294:Gamma-carboxyglutamic acid-rich (GLA) domain,																					SM00069:GLA,				transmembrane region,topological domain:Extracellular,topological domain:Cytoplasmic,sequence variant,sequence conflict,modified residue,domain:Gla,disulfide bond,chain:Transmembrane gamma-carboxyglutamic acid protein 3,									
5126	proprotein convertase subtilisin/kexin type 2(PCSK2)	Homo sapiens						GO:1901142~insulin metabolic process,GO:0051604~protein maturation,GO:0043603~cellular amide metabolic process,GO:0042445~hormone metabolic process,GO:0034231~islet amyloid polypeptide processing,GO:0034230~enkephalin processing,GO:0030070~insulin processing,GO:0016540~protein autoprocessing,GO:0016486~peptide hormone processing,GO:0016485~protein processing,GO:0010817~regulation of hormone levels,GO:0010467~gene expression,GO:0007399~nervous system development,GO:0006518~peptide metabolic process,GO:0006508~proteolysis,											GO:0099503~secretory vesicle,GO:0097458~neuron part,GO:0060205~cytoplasmic membrane-bounded vesicle lumen,GO:0044433~cytoplasmic vesicle part,GO:0044421~extracellular region part,GO:0044297~cell body,GO:0043204~perikaryon,GO:0043025~neuronal cell body,GO:0043005~neuron projection,GO:0036477~somatodendritic compartment,GO:0034774~secretory granule lumen,GO:0031988~membrane-bounded vesicle,GO:0031983~vesicle lumen,GO:0030425~dendrite,GO:0030141~secretory granule,GO:0030133~transport vesicle,GO:0016023~cytoplasmic, membrane-bounded vesicle,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0070011~peptidase activity, acting on L-amino acid peptides,GO:0044877~macromolecular complex binding,GO:0032403~protein complex binding,GO:0017171~serine hydrolase activity,GO:0008236~serine-type peptidase activity,GO:0008233~peptidase activity,GO:0004252~serine-type endopeptidase activity,GO:0004175~endopeptidase activity,						IPR023828:Peptidase S8, subtilisin, Ser-active site,IPR023827:Peptidase S8, subtilisin,  Asp-active site,IPR022398:Peptidase S8, subtilisin, His-active site,IPR015500:Peptidase S8, subtilisin-related,IPR009020:Proteinase inhibitor, propeptide,IPR008979:Galactose-binding domain-like,IPR002884:Proprotein convertase, P,IPR000209:Peptidase S8/S53 domain,													signal peptide,sequence variant,sequence conflict,region of interest:Catalytic,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Neuroendocrine convertase 2,active site:Charge relay system,									
6039	ribonuclease A family member k6(RNASE6)	Homo sapiens						GO:1901361~organic cyclic compound catabolic process,GO:0090501~RNA phosphodiester bond hydrolysis,GO:0090305~nucleic acid phosphodiester bond hydrolysis,GO:0046700~heterocycle catabolic process,GO:0044270~cellular nitrogen compound catabolic process,GO:0044265~cellular macromolecule catabolic process,GO:0044248~cellular catabolic process,GO:0034655~nucleobase-containing compound catabolic process,GO:0019439~aromatic compound catabolic process,GO:0016070~RNA metabolic process,GO:0009057~macromolecule catabolic process,GO:0006952~defense response,GO:0006401~RNA catabolic process,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0005576~extracellular region,															GO:1901363~heterocyclic compound binding,GO:0097159~organic cyclic compound binding,GO:0004540~ribonuclease activity,GO:0004519~endonuclease activity,GO:0004518~nuclease activity,GO:0003676~nucleic acid binding,						IPR023412:Ribonuclease A-domain,IPR023411:Ribonuclease A, active site,IPR001427:Ribonuclease A,																					SM00092:RNAse_Pc,				signal peptide,sequence variant,region of interest:Substrate binding,glycosylation site:N-linked (GlcNAc...),disulfide bond,chain:Ribonuclease K6,binding site:Substrate,active site:Proton donor,active site:Proton acceptor,									
6588	sarcolipin(SLN)	Homo sapiens						GO:1904063~negative regulation of cation transmembrane transport,GO:1904062~regulation of cation transmembrane transport,GO:1903170~negative regulation of calcium ion transmembrane transport,GO:1903169~regulation of calcium ion transmembrane transport,GO:1901894~regulation of calcium-transporting ATPase activity,GO:1901881~positive regulation of protein depolymerization,GO:1901879~regulation of protein depolymerization,GO:1901877~negative regulation of calcium ion binding,GO:1901876~regulation of calcium ion binding,GO:1901077~regulation of relaxation of muscle,GO:1901020~negative regulation of calcium ion transmembrane transporter activity,GO:1901019~regulation of calcium ion transmembrane transporter activity,GO:0098662~inorganic cation transmembrane transport,GO:0098660~inorganic ion transmembrane transport,GO:0098655~cation transmembrane transport,GO:0090281~negative regulation of calcium ion import,GO:0090279~regulation of calcium ion import,GO:0090257~regulation of muscle system process,GO:0072511~divalent inorganic cation transport,GO:0071822~protein complex subunit organization,GO:0070838~divalent metal ion transport,GO:0070588~calcium ion transmembrane transport,GO:0070509~calcium ion import,GO:0070296~sarcoplasmic reticulum calcium ion transport,GO:0065009~regulation of molecular function,GO:0055085~transmembrane transport,GO:0051926~negative regulation of calcium ion transport,GO:0051924~regulation of calcium ion transport,GO:0051336~regulation of hydrolase activity,GO:0051261~protein depolymerization,GO:0051130~positive regulation of cellular component organization,GO:0051129~negative regulation of cellular component organization,GO:0051128~regulation of cellular component organization,GO:0051100~negative regulation of binding,GO:0051098~regulation of binding,GO:0051051~negative regulation of transport,GO:0051049~regulation of transport,GO:0050790~regulation of catalytic activity,GO:0044092~negative regulation of molecular function,GO:0044057~regulation of system process,GO:0043933~macromolecular complex subunit organization,GO:0043624~cellular protein complex disassembly,GO:0043462~regulation of ATPase activity,GO:0043271~negative regulation of ion transport,GO:0043269~regulation of ion transport,GO:0043244~regulation of protein complex disassembly,GO:0043243~positive regulation of protein complex disassembly,GO:0043242~negative regulation of protein complex disassembly,GO:0043241~protein complex disassembly,GO:0043086~negative regulation of catalytic activity,GO:0034766~negative regulation of ion transmembrane transport,GO:0034765~regulation of ion transmembrane transport,GO:0034763~negative regulation of transmembrane transport,GO:0034762~regulation of transmembrane transport,GO:0034220~ion transmembrane transport,GO:0032984~macromolecular complex disassembly,GO:0032413~negative regulation of ion transmembrane transporter activity,GO:0032412~regulation of ion transmembrane transporter activity,GO:0032410~negative regulation of transporter activity,GO:0032409~regulation of transporter activity,GO:0030001~metal ion transport,GO:0022898~regulation of transmembrane transporter activity,GO:0022411~cellular component disassembly,GO:0010959~regulation of metal ion transport,GO:0006816~calcium ion transport,GO:0006812~cation transport,GO:0006811~ion transport,GO:0003012~muscle system process,GO:0003008~system process,											GO:0044432~endoplasmic reticulum part,GO:0042175~nuclear outer membrane-endoplasmic reticulum membrane network,GO:0033017~sarcoplasmic reticulum membrane,GO:0016529~sarcoplasmic reticulum,GO:0016528~sarcoplasm,GO:0005789~endoplasmic reticulum membrane,GO:0005783~endoplasmic reticulum,															GO:0098772~molecular function regulator,GO:0051117~ATPase binding,GO:0030234~enzyme regulator activity,GO:0019899~enzyme binding,GO:0004857~enzyme inhibitor activity,						IPR008028:Sarcolipin,													transmembrane region,strand,peptide:Sarcolipin,helix,									
57152	secreted LY6/PLAUR domain containing 1(SLURP1)	Homo sapiens						GO:2000146~negative regulation of cell motility,GO:2000145~regulation of cell motility,GO:0051674~localization of cell,GO:0051271~negative regulation of cellular component movement,GO:0051270~regulation of cellular component movement,GO:0050905~neuromuscular process,GO:0050884~neuromuscular process controlling posture,GO:0050877~neurological system process,GO:0050680~negative regulation of epithelial cell proliferation,GO:0050678~regulation of epithelial cell proliferation,GO:0050673~epithelial cell proliferation,GO:0048870~cell motility,GO:0043616~keratinocyte proliferation,GO:0042127~regulation of cell proliferation,GO:0040013~negative regulation of locomotion,GO:0040012~regulation of locomotion,GO:0040011~locomotion,GO:0030336~negative regulation of cell migration,GO:0030334~regulation of cell migration,GO:0022610~biological adhesion,GO:0016477~cell migration,GO:0010839~negative regulation of keratinocyte proliferation,GO:0010837~regulation of keratinocyte proliferation,GO:0008285~negative regulation of cell proliferation,GO:0008283~cell proliferation,GO:0007626~locomotory behavior,GO:0007610~behavior,GO:0007155~cell adhesion,GO:0006928~movement of cell or subcellular component,GO:0003008~system process,GO:0001775~cell activation,											GO:1903561~extracellular vesicle,GO:0070062~extracellular exosome,GO:0044421~extracellular region part,GO:0043230~extracellular organelle,GO:0031988~membrane-bounded vesicle,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0005125~cytokine activity,GO:0005102~receptor binding,						IPR027103:Secreted Ly-6/uPAR-related protein 1,IPR016054:Ly-6 antigen / uPA receptor -like,														248300~Meleda disease,											signal peptide,sequence variant,sequence conflict,domain:UPAR/Ly6,disulfide bond,chain:Secreted Ly-6/uPAR-related protein 1,									
6343	secretin(SCT)	Homo sapiens						GO:1903640~negative regulation of gastrin-induced gastric acid secretion,GO:1903639~regulation of gastrin-induced gastric acid secretion,GO:1903532~positive regulation of secretion by cell,GO:1903530~regulation of secretion by cell,GO:1901566~organonitrogen compound biosynthetic process,GO:1901293~nucleoside phosphate biosynthetic process,GO:1901137~carbohydrate derivative biosynthetic process,GO:1901135~carbohydrate derivative metabolic process,GO:1900544~positive regulation of purine nucleotide metabolic process,GO:1900542~regulation of purine nucleotide metabolic process,GO:1900373~positive regulation of purine nucleotide biosynthetic process,GO:1900371~regulation of purine nucleotide biosynthetic process,GO:0090407~organophosphate biosynthetic process,GO:0090277~positive regulation of peptide hormone secretion,GO:0090276~regulation of peptide hormone secretion,GO:0090274~positive regulation of somatostatin secretion,GO:0090273~regulation of somatostatin secretion,GO:0090187~positive regulation of pancreatic juice secretion,GO:0090186~regulation of pancreatic juice secretion,GO:0090087~regulation of peptide transport,GO:0072522~purine-containing compound biosynthetic process,GO:0072521~purine-containing compound metabolic process,GO:0071705~nitrogen compound transport,GO:0070253~somatostatin secretion,GO:0060457~negative regulation of digestive system process,GO:0060456~positive regulation of digestive system process,GO:0060455~negative regulation of gastric acid secretion,GO:0060453~regulation of gastric acid secretion,GO:0060322~head development,GO:0055123~digestive system development,GO:0055086~nucleobase-containing small molecule metabolic process,GO:0052652~cyclic purine nucleotide metabolic process,GO:0051241~negative regulation of multicellular organismal process,GO:0051240~positive regulation of multicellular organismal process,GO:0051174~regulation of phosphorus metabolic process,GO:0051173~positive regulation of nitrogen compound metabolic process,GO:0051171~regulation of nitrogen compound metabolic process,GO:0051051~negative regulation of transport,GO:0051050~positive regulation of transport,GO:0051049~regulation of transport,GO:0051048~negative regulation of secretion,GO:0051047~positive regulation of secretion,GO:0051046~regulation of secretion,GO:0050878~regulation of body fluid levels,GO:0048568~embryonic organ development,GO:0048566~embryonic digestive tract development,GO:0048565~digestive tract development,GO:0046903~secretion,GO:0046887~positive regulation of hormone secretion,GO:0046883~regulation of hormone secretion,GO:0046879~hormone secretion,GO:0046717~acid secretion,GO:0046390~ribose phosphate biosynthetic process,GO:0046058~cAMP metabolic process,GO:0045981~positive regulation of nucleotide metabolic process,GO:0045937~positive regulation of phosphate metabolic process,GO:0045935~positive regulation of nucleobase-containing compound metabolic process,GO:0044058~regulation of digestive system process,GO:0044057~regulation of system process,GO:0042886~amide transport,GO:0035295~tube development,GO:0034654~nucleobase-containing compound biosynthetic process,GO:0032941~secretion by tissue,GO:0032940~secretion by cell,GO:0031328~positive regulation of cellular biosynthetic process,GO:0031325~positive regulation of cellular metabolic process,GO:0030819~positive regulation of cAMP biosynthetic process,GO:0030817~regulation of cAMP biosynthetic process,GO:0030816~positive regulation of cAMP metabolic process,GO:0030814~regulation of cAMP metabolic process,GO:0030810~positive regulation of nucleotide biosynthetic process,GO:0030808~regulation of nucleotide biosynthetic process,GO:0030804~positive regulation of cyclic nucleotide biosynthetic process,GO:0030802~regulation of cyclic nucleotide biosynthetic process,GO:0030801~positive regulation of cyclic nucleotide metabolic process,GO:0030799~regulation of cyclic nucleotide metabolic process,GO:0030157~pancreatic juice secretion,GO:0030072~peptide hormone secretion,GO:0023061~signal release,GO:0023056~positive regulation of signaling,GO:0023051~regulation of signaling,GO:0022600~digestive system process,GO:0019693~ribose phosphate metabolic process,GO:0019637~organophosphate metabolic process,GO:0019438~aromatic compound biosynthetic process,GO:0019220~regulation of phosphate metabolic process,GO:0019219~regulation of nucleobase-containing compound metabolic process,GO:0018130~heterocycle biosynthetic process,GO:0015833~peptide transport,GO:0010817~regulation of hormone levels,GO:0010647~positive regulation of cell communication,GO:0010646~regulation of cell communication,GO:0010562~positive regulation of phosphorus metabolic process,GO:0009914~hormone transport,GO:0009893~positive regulation of metabolic process,GO:0009891~positive regulation of biosynthetic process,GO:0009790~embryo development,GO:0009260~ribonucleotide biosynthetic process,GO:0009259~ribonucleotide metabolic process,GO:0009190~cyclic nucleotide biosynthetic process,GO:0009187~cyclic nucleotide metabolic process,GO:0009165~nucleotide biosynthetic process,GO:0009152~purine ribonucleotide biosynthetic process,GO:0009150~purine ribonucleotide metabolic process,GO:0009117~nucleotide metabolic process,GO:0007589~body fluid secretion,GO:0007586~digestion,GO:0007420~brain development,GO:0007417~central nervous system development,GO:0007399~nervous system development,GO:0007267~cell-cell signaling,GO:0006796~phosphate-containing compound metabolic process,GO:0006793~phosphorus metabolic process,GO:0006753~nucleoside phosphate metabolic process,GO:0006171~cAMP biosynthetic process,GO:0006164~purine nucleotide biosynthetic process,GO:0006163~purine nucleotide metabolic process,GO:0006140~regulation of nucleotide metabolic process,GO:0003008~system process,GO:0002793~positive regulation of peptide secretion,GO:0002791~regulation of peptide secretion,GO:0002790~peptide secretion,GO:0001698~gastrin-induced gastric acid secretion,GO:0001696~gastric acid secretion,											GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,															GO:0047485~protein N-terminus binding,GO:0005179~hormone activity,GO:0005102~receptor binding,						IPR015675:Secretin,IPR000532:Glucagon/GIP/secretin/VIP,																					SM00070:GLUCA,				signal peptide,peptide:Secretin,modified residue,									
10647	secretoglobin family 1D member 2(SCGB1D2)	Homo sapiens					GO:0044421~extracellular region part,GO:0005615~extracellular space,GO:0005576~extracellular region,									IPR016126:Secretoglobin,													signal peptide,sequence variant,chain:Secretoglobin family 1D member 2,									
284402	secretoglobin family 2B member 2(SCGB2B2)	Homo sapiens					GO:0005576~extracellular region,									IPR016126:Secretoglobin,													signal peptide,chain:Secretoglobin-like protein,									
153328	solute carrier family 25 member 48(SLC25A48)	Homo sapiens						GO:1901566~organonitrogen compound biosynthetic process,GO:0055085~transmembrane transport,GO:0043604~amide biosynthetic process,GO:0043603~cellular amide metabolic process,GO:0043043~peptide biosynthetic process,GO:0034645~cellular macromolecule biosynthetic process,GO:0010467~gene expression,GO:0006518~peptide metabolic process,GO:0006412~translation,											GO:0044429~mitochondrial part,GO:0031975~envelope,GO:0031967~organelle envelope,GO:0031966~mitochondrial membrane,GO:0019866~organelle inner membrane,GO:0005743~mitochondrial inner membrane,GO:0005740~mitochondrial envelope,GO:0005739~mitochondrion,															GO:0005198~structural molecule activity,GO:0003735~structural constituent of ribosome,						IPR023395:Mitochondrial carrier domain,IPR018108:Mitochondrial substrate/solute carrier,IPR002067:Mitochondrial carrier protein,													transmembrane region,splice variant,repeat:Solcar 3,repeat:Solcar 2,repeat:Solcar 1,chain:Putative mitochondrial carrier protein FLJ44862,									